Central	B-cell_type
nervous	I-cell_type
system-derived	I-cell_type
cells	I-cell_type
express	O
a	O
kappa	O
B-binding	O
activity	O
that	O
enhances	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
transcription	O
in	O
vitro	O
and	O
facilitates	O
TAR	B-DNA
-independent	O
transactivation	O
by	O
Tat	B-protein
.	O

The	O
Tat	B-protein
protein	I-protein
of	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
(	O
HIV-1	O
)	O
is	O
a	O
potent	O
activator	O
of	O
long	B-DNA
terminal	I-DNA
repeat	I-DNA
-directed	O
transcription	O
.	O

While	O
in	O
most	O
cell	O
types	O
,	O
activation	O
requires	O
interaction	O
of	O
Tat	O
with	O
the	O
unusual	O
transcription	B-DNA
element	I-DNA
TAR	B-DNA
,	O
astrocytic	B-cell_type
glial	I-cell_type
cells	I-cell_type
support	O
TAR	B-DNA
-independent	O
transactivation	O
of	O
HIV-1	O
transcription	O
by	O
Tat	O
.	O

This	O
alternative	O
pathway	O
of	O
Tat	B-protein
activation	O
is	O
mediated	O
by	O
the	O
viral	B-DNA
enhancer	I-DNA
,	O
a	O
kappa	O
B	O
domain	O
capable	O
of	O
binding	O
the	O
prototypical	O
form	O
of	O
the	O
transcription	B-protein
factor	I-protein
nuclear	O
factor	O
kappa	O
B	O
(	O
NF-kappa	B-protein
B	I-protein
)	O
present	O
in	O
many	O
cell	O
types	O
,	O
including	O
T	B-cell_type
lymphocytes	I-cell_type
.	O

Tat	B-protein
transactivation	O
mediated	O
by	O
the	O
kappa	B-DNA
B	I-DNA
domain	I-DNA
is	O
sufficient	O
to	O
allow	O
replication	O
of	O
TAR	B-DNA
-deleted	O
mutant	O
HIV-1	O
in	O
astrocytes	B-cell_type
.	O

The	O
present	O
study	O
demonstrates	O
the	O
existence	O
of	O
kappa	B-protein
B-specific	I-protein
binding	I-protein
factors	I-protein
present	O
in	O
human	B-cell_type
glial	I-cell_type
astrocytes	I-cell_type
that	O
differ	O
from	O
prototypical	O
NF-kappa	B-protein
B	I-protein
.	O

The	O
novel	O
astrocyte-derived	O
kappa	O
B-binding	O
activity	O
is	O
retained	O
on	O
an	O
HIV-1	O
Tat	B-protein
affinity	O
column	O
,	O
while	O
prototypical	O
NF-kappa	B-protein
B	I-protein
from	O
Jurkat	B-cell_line
T	I-cell_line
cells	I-cell_line
is	O
not	O
.	O

In	O
vitro	O
transcription	O
studies	O
demonstrate	O
that	O
astrocyte-derived	B-protein
kappa	I-protein
B-binding	I-protein
factors	I-protein
activate	O
transcription	O
of	O
the	O
HIV-1	B-DNA
long	I-DNA
terminal	I-DNA
repeat	I-DNA
and	O
that	O
this	O
activation	O
is	O
dependent	O
on	O
the	O
kappa	B-DNA
B	I-DNA
domain	I-DNA
.	O

Moreover	O
,	O
TAR	B-DNA
-independent	O
transactivation	O
of	O
HIV-1	O
transcription	O
is	O
reproduced	O
in	O
vitro	O
in	O
an	O
astrocyte	O
factor-dependent	O
manner	O
which	O
correlates	O
with	O
kappa	O
B-binding	O
activity	O
.	O

The	O
importance	O
of	O
the	O
central	B-protein
nervous	I-protein
system-enriched	I-protein
kappa	I-protein
B	I-protein
transcription	B-protein
factor	I-protein
in	O
the	O
regulation	O
of	O
HIV-1	O
expression	O
is	O
discussed	O
.	O

JOURNAL	NULL
OF	NULL
VIROLOGY	NULL
,	NULL
June	NULL
1994	NULL
,	NULL
p.	NULL
3971-3981	NULL
0022-538	NULL
X/94/	NULL
$	NULL
04.00	NULL
+0	NULL
Copyright	NULL
©	NULL
1994	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

68	NULL
,	NULL
No	NULL
.	NULL

6	NULL
Central	NULL
Nervous	NULL
System-Derived	NULL
Cells	NULL
Express	NULL
a	NULL
«	NULL
<	NULL
B-Binding	NULL
Activity	NULL
That	NULL
Enhances	NULL
Human	NULL
Immunodeficiency	NULL
Virus	NULL
Type	NULL
1	NULL
Transcription	NULL
In	NULL
Vitro	NULL
and	NULL
Facilitates	NULL
TAR-Independent	NULL
Transactivation	NULL
by	NULL
Tat	NULL
J.	NULL
PAUL	NULL
TAYLOR	NULL
,	NULL
``	NULL
ROGER	NULL
J.	NULL
POMERANTZ	NULL
,	NULL
``	NULL
GANESH	NULL
V.	NULL
RAJ	NULL
,	NULL
``	NULL
FATAH	NULL
KASHANCHLI	NULL
,	NULL
*	NULL
JOHN	NULL
N.	NULL
BRADY	NULL
,	NULL
``	NULL
SHOHREH	NULL
AMINI	NULL
,	NULL
!	NULL

anp	NULL
KAMEL	NULL
KHALILL'*	NULL
Molecular	NULL
Neurovirology	NULL
Section	NULL
,	NULL
Jefferson	NULL
Institute	NULL
of	NULL
Molecular	NULL
Medicine	NULL
,	NULL
Department	NULL
of	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Thomas	NULL
Jefferson	NULL
University	NULL
,	NULL
``	NULL
and	NULL
Division	NULL
of	NULL
Infectious	NULL
Disease	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Jefferson	NULL
Medical	NULL
College	NULL
,	NULL
``	NULL
Philadelphia	NULL
,	NULL
Pennsylvania	NULL
19107	NULL
,	NULL
and	NULL
Laboratory	NULL
of	NULL
Molecular	NULL
Virology	NULL
,	NULL
National	NULL
Cancer	NULL
Institute	NULL
,	NULL
Bethesda	NULL
,	NULL
Maryland	NULL
20892	NULL
%	NULL
Received	NULL
13	NULL
September	NULL
1993/Accepted	NULL
17	NULL
March	NULL
1994	NULL
The	NULL
Tat	NULL
protein	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
is	NULL
a	NULL
potent	NULL
activator	NULL
of	NULL
long	NULL
terminal	NULL
repeat-directed	NULL
transcription	NULL
.	NULL

While	NULL
in	NULL
most	NULL
cell	NULL
types	NULL
,	NULL
activation	NULL
requires	NULL
interaction	NULL
of	NULL
Tat	NULL
with	NULL
the	NULL
unusual	NULL
transcription	NULL
element	NULL
TAR	NULL
,	NULL
astrocytic	NULL
glial	NULL
cells	NULL
support	NULL
TAR-independent	NULL
transactivation	NULL
of	NULL
HIV-1	NULL
transcription	NULL
by	NULL
Tat	NULL
.	NULL

This	NULL
alternative	NULL
pathway	NULL
of	NULL
Tat	NULL
activation	NULL
is	NULL
mediated	NULL
by	NULL
the	NULL
viral	NULL
enhancer	NULL
,	NULL
a	NULL
«	NULL
B	NULL
domain	NULL
capable	NULL
of	NULL
binding	NULL
the	NULL
prototypical	NULL
form	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
nuclear	NULL
factor	NULL
kappa	NULL
B	NULL
(	NULL
NF-KB	NULL
)	NULL
present	NULL
in	NULL
many	NULL
cell	NULL
types	NULL
,	NULL
including	NULL
T	NULL
lymphocytes	NULL
.	NULL

Tat	NULL
transactivation	NULL
mediated	NULL
by	NULL
the	NULL
«	NULL
B	NULL
domain	NULL
is	NULL
sufficient	NULL
to	NULL
allow	NULL
replication	NULL
of	NULL
TAR-deleted	NULL
mutant	NULL
HIV-1	NULL
in	NULL
astrocytes	NULL
.	NULL

The	NULL
present	NULL
study	NULL
demonstrates	NULL
the	NULL
existence	NULL
of	NULL
«	NULL
B-specific	NULL
binding	NULL
factors	NULL
present	NULL
in	NULL
human	NULL
glial	NULL
astrocytes	NULL
that	NULL
differ	NULL
from	NULL
prototypical	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

The	NULL
novel	NULL
astrocyte-derived	NULL
<	NULL
B-binding	NULL
activity	NULL
is	NULL
retained	NULL
on	NULL
an	NULL
HIV-1	NULL
Tat	NULL
affinity	NULL
column	NULL
,	NULL
while	NULL
prototypical	NULL
NF-B	NULL
from	NULL
Jurkat	NULL
T	NULL
cells	NULL
is	NULL
not	NULL
.	NULL

In	NULL
vitro	NULL
transcription	NULL
studies	NULL
demonstrate	NULL
that	NULL
astrocyte-derived	NULL
«	NULL
B-binding	NULL
factors	NULL
activate	NULL
transcription	NULL
of	NULL
the	NULL
HIV-1	NULL
long	NULL
terminal	NULL
repeat	NULL
and	NULL
that	NULL
this	NULL
activation	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
B	NULL
domain	NULL
.	NULL

Moreover	NULL
,	NULL
TAR-independent	NULL
transactivation	NULL
of	NULL
HIV-1	NULL
transcription	NULL
is	NULL
reproduced	NULL
in	NULL
vitro	NULL
in	NULL
an	NULL
astrocyte	NULL
factor-dependent	NULL
manner	NULL
which	NULL
correlates	NULL
with	NULL
«	NULL
B-binding	NULL
activity	NULL
.	NULL

The	NULL
importance	NULL
of	NULL
the	NULL
central	NULL
nervous	NULL
system-enriched	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
HIV-1	NULL
expression	NULL
is	NULL
discussed	NULL
.	NULL

The	NULL
tat	NULL
gene	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
is	NULL
essential	NULL
for	NULL
viral	NULL
replication	NULL
(	NULL
16	NULL
,	NULL
20	NULL
)	NULL
.	NULL

Tat	NULL
is	NULL
expressed	NULL
early	NULL
in	NULL
the	NULL
viral	NULL
life	NULL
cycle	NULL
and	NULL
serves	NULL
as	NULL
a	NULL
potent	NULL
activator	NULL
of	NULL
transcription	NULL
directed	NULL
by	NULL
the	NULL
HIV-1	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
,	NULL
leading	NULL
to	NULL
the	NULL
increased	NULL
expression	NULL
of	NULL
all	NULL
viral	NULL
genes	NULL
(	NULL
1	NULL
,	NULL
54	NULL
)	NULL
.	NULL

Tat	NULL
binds	NULL
to	NULL
a	NULL
specific	NULL
RNA	NULL
structure	NULL
,	NULL
termed	NULL
the	NULL
TAR	NULL
element	NULL
,	NULL
found	NULL
at	NULL
the	NULL
5	NULL
end	NULL
of	NULL
all	NULL
HIV-1	NULL
mRNAs	NULL
(	NULL
12	NULL
,	NULL
13	NULL
,	NULL
39	NULL
,	NULL
49	NULL
)	NULL
.	NULL

Experiments	NULL
carried	NULL
out	NULL
with	NULL
a	NULL
limited	NULL
number	NULL
of	NULL
cell	NULL
types	NULL
,	NULL
primarily	NULL
HeLa	NULL
cells	NULL
and	NULL
T-lymphocytic	NULL
cell	NULL
lines	NULL
,	NULL
indicate	NULL
that	NULL
the	NULL
interaction	NULL
of	NULL
Tat	NULL
with	NULL
this	NULL
specific	NULL
RNA	NULL
target	NULL
is	NULL
an	NULL
important	NULL
component	NULL
of	NULL
the	NULL
activation	NULL
mechanism	NULL
(	NULL
8	NULL
,	NULL
12	NULL
,	NULL
13	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
suggested	NULL
that	NULL
binding	NULL
to	NULL
TAR	NULL
serves	NULL
to	NULL
localize	NULL
Tat	NULL
to	NULL
the	NULL
vicinity	NULL
of	NULL
the	NULL
promoter	NULL
,	NULL
where	NULL
it	NULL
interacts	NULL
with	NULL
unspecified	NULL
targets	NULL
,	NULL
resulting	NULL
in	NULL
enhanced	NULL
transcriptional	NULL
initiation	NULL
(	NULL
53	NULL
)	NULL
.	NULL

This	NULL
model	NULL
of	NULL
Tat	NULL
function	NULL
is	NULL
consistent	NULL
with	NULL
results	NULL
implicating	NULL
the	NULL
participation	NULL
of	NULL
specific	NULL
upstream	NULL
regulatory	NULL
elements	NULL
of	NULL
the	NULL
viral	NULL
LTR	NULL
,	NULL
such	NULL
as	NULL
the	NULL
kB	NULL
domain	NULL
and	NULL
the	NULL
GC-rich	NULL
Spl-binding	NULL
sites	NULL
,	NULL
in	NULL
Tat	NULL
transactivation	NULL
(	NULL
7	NULL
,	NULL
30	NULL
,	NULL
55	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
with	NULL
kinetic	NULL
studies	NULL
which	NULL
suggest	NULL
that	NULL
a	NULL
transient	NULL
interaction	NULL
between	NULL
Tat	NULL
and	NULL
nascent	NULL
TAR	NULL
RNA	NULL
is	NULL
sufficient	NULL
for	NULL
achieving	NULL
wild-type	NULL
levels	NULL
of	NULL
transactivation	NULL
(	NULL
7	NULL
,	NULL
8	NULL
,	NULL
28	NULL
,	NULL
30	NULL
,	NULL
53	NULL
,	NULL
55	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
a	NULL
number	NULL
of	NULL
reports	NULL
have	NULL
suggested	NULL
that	NULL
the	NULL
primary	NULL
function	NULL
of	NULL
Tat	NULL
is	NULL
to	NULL
increase	NULL
the	NULL
efficiency	NULL
of	NULL
transcriptional	NULL
elongation	NULL
(	NULL
19	NULL
,	NULL
36	NULL
)	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
Tat	NULL
to	NULL
influence	NULL
elongation	NULL
seems	NULL
surprising	NULL
in	NULL
light	NULL
of	NULL
evidence	NULL
that	NULL
the	NULL
target	NULL
of	NULL
Tat	NULL
function	NULL
is	NULL
at	NULL
the	NULL
promoter	NULL
(	NULL
7	NULL
,	NULL
30	NULL
,	NULL
52	NULL
,	NULL
55	NULL
)	NULL
and	NULL
that	NULL
the	NULL
kinetics	NULL
of	NULL
Tat	NULL
function	NULL
indicate	NULL
an	NULL
effect	NULL
at	NULL
the	NULL
time	NULL
of	NULL
,	NULL
or	NULL
immediately	NULL
after	NULL
,	NULL
initiation	NULL
of	NULL
transcription	NULL
(	NULL
28	NULL
)	NULL
.	NULL

In	NULL
an	NULL
attempt	NULL
to	NULL
resolve	NULL
this	NULL
apparent	NULL
paradox	NULL
,	NULL
it	NULL
has	NULL
been	NULL
proposed	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
215	NULL
)	NULL
955-5534	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
215	NULL
)	NULL
923-8021	NULL
.	NULL

3971	NULL
that	NULL
Tat	NULL
functions	NULL
at	NULL
the	NULL
promoter	NULL
of	NULL
HIV-1	NULL
,	NULL
requiring	NULL
the	NULL
participation	NULL
of	NULL
upstream	NULL
regulatory	NULL
elements	NULL
,	NULL
and	NULL
biases	NULL
initiation	NULL
towards	NULL
the	NULL
formation	NULL
of	NULL
``	NULL
more-processive	NULL
``	NULL
transcription	NULL
complexes	NULL
(	NULL
22	NULL
)	NULL
.	NULL

The	NULL
clinical	NULL
course	NULL
of	NULL
HIV	NULL
disease	NULL
is	NULL
frequently	NULL
complicated	NULL
by	NULL
multiple	NULL
disorders	NULL
of	NULL
the	NULL
central	NULL
nervous	NULL
system	NULL
(	NULL
CNS	NULL
)	NULL
(	NULL
47	NULL
,	NULL
48	NULL
)	NULL
.	NULL

At	NULL
least	NULL
60	NULL
%	NULL
of	NULL
AIDS	NULL
patients	NULL
exhibit	NULL
clinical	NULL
symptoms	NULL
of	NULL
neurologic	NULL
disease	NULL
,	NULL
and	NULL
90	NULL
%	NULL
demonstrate	NULL
neuropathologic	NULL
abnormalities	NULL
at	NULL
autopsy	NULL
(	NULL
32	NULL
,	NULL
42	NULL
)	NULL
.	NULL

While	NULL
HIV-1	NULL
predominantly	NULL
infects	NULL
microglial	NULL
cells	NULL
in	NULL
the	NULL
CNS	NULL
,	NULL
viral	NULL
antigens	NULL
have	NULL
also	NULL
been	NULL
detected	NULL
in	NULL
astrocytes	NULL
in	NULL
vivo	NULL
(	NULL
25	NULL
,	NULL
57	NULL
)	NULL
,	NULL
and	NULL
it	NULL
has	NULL
been	NULL
demonstrated	NULL
that	NULL
HIV-1	NULL
infects	NULL
glial	NULL
astrocytes	NULL
in	NULL
vitro	NULL
(	NULL
14	NULL
,	NULL
15	NULL
,	NULL
17	NULL
)	NULL
.	NULL

Studies	NULL
examining	NULL
the	NULL
regulation	NULL
of	NULL
HIV-1	NULL
gene	NULL
expression	NULL
in	NULL
cells	NULL
derived	NULL
from	NULL
the	NULL
CNS	NULL
revealed	NULL
that	NULL
glial	NULL
astrocytes	NULL
support	NULL
TAR-independent	NULL
activation	NULL
of	NULL
HIV-1	NULL
transcription	NULL
by	NULL
Tat	NULL
(	NULL
60	NULL
)	NULL
.	NULL

The	NULL
alternative	NULL
pathway	NULL
of	NULL
Tat	NULL
utilization	NULL
in	NULL
glial	NULL
astrocytes	NULL
was	NULL
found	NULL
to	NULL
allow	NULL
HIV-1	NULL
replication	NULL
to	NULL
circumvent	NULL
the	NULL
requirement	NULL
for	NULL
a	NULL
functional	NULL
TAR	NULL
element	NULL
(	NULL
6	NULL
,	NULL
60	NULL
)	NULL
.	NULL

We	NULL
further	NULL
determined	NULL
that	NULL
the	NULL
RNA-binding	NULL
domain	NULL
of	NULL
Tat	NULL
protein	NULL
was	NULL
dispensable	NULL
for	NULL
TAR-independent	NULL
transactivation	NULL
but	NULL
that	NULL
the	NULL
activation	NULL
domain	NULL
of	NULL
the	NULL
protein	NULL
remained	NULL
necessary	NULL
(	NULL
59	NULL
)	NULL
.	NULL

The	NULL
kB	NULL
domain	NULL
within	NULL
the	NULL
HIV-1	NULL
LTR	NULL
,	NULL
also	NULL
referred	NULL
to	NULL
as	NULL
the	NULL
viral	NULL
enhancer	NULL
,	NULL
was	NULL
determined	NULL
to	NULL
be	NULL
Tat	NULL
responsive	NULL
within	NULL
astrocytes	NULL
,	NULL
conferring	NULL
Tat	NULL
responsiveness	NULL
to	NULL
heterologous	NULL
promoters	NULL
and	NULL
permitting	NULL
TAR-independent	NULL
replication	NULL
of	NULL
HIV-1	NULL
(	NULL
6	NULL
,	NULL
60	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
clearly	NULL
differed	NULL
from	NULL
many	NULL
previous	NULL
reports	NULL
concerning	NULL
lymphocytes	NULL
and	NULL
monocytes	NULL
,	NULL
where	NULL
TAR	NULL
is	NULL
reported	NULL
to	NULL
be	NULL
absolutely	NULL
essential	NULL
for	NULL
Tat	NULL
transactivation	NULL
and	NULL
viral	NULL
replication	NULL
,	NULL
and	NULL
suggested	NULL
the	NULL
potential	NULL
for	NULL
differential	NULL
utilization	NULL
of	NULL
kB	NULL
elements	NULL
within	NULL
astrocytes	NULL
.	NULL

Further	NULL
,	NULL
these	NULL
observations	NULL
may	NULL
provide	NULL
insight	NULL
3972	NULL
TAYLOR	NULL
ET	NULL
AL	NULL
.	NULL

into	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
Tat	NULL
influences	NULL
cellular	NULL
gene	NULL
expression	NULL
.	NULL

The	NULL
HIV-1	NULL
enhancer	NULL
found	NULL
between	NULL
nucleotides	NULL
-80	NULL
and	NULL
-105	NULL
of	NULL
the	NULL
viral	NULL
LTR	NULL
contains	NULL
two	NULL
tandem	NULL
repeats	NULL
of	NULL
the	NULL
decanucleotide	NULL
sequence	NULL
5-GGGACTTTCC-3	NULL
'	NULL
which	NULL
have	NULL
been	NULL
found	NULL
to	NULL
bind	NULL
two	NULL
copies	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Induction	NULL
of	NULL
NF-kB	NULL
binding	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
increased	NULL
HIV-1	NULL
transcription	NULL
observed	NULL
upon	NULL
activation	NULL
of	NULL
T	NULL
lymphocytes	NULL
by	NULL
specific	NULL
antigen	NULL
or	NULL
stimulation	NULL
with	NULL
mitogens	NULL
such	NULL
as	NULL
phorbol	NULL
esters	NULL
and	NULL
lectins	NULL
(	NULL
40	NULL
)	NULL
.	NULL

This	NULL
activation	NULL
works	NULL
in	NULL
concert	NULL
with	NULL
Tat	NULL
in	NULL
stimulating	NULL
HIV-1	NULL
gene	NULL
expression	NULL
(	NULL
34	NULL
,	NULL
40	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
«	NULL
B	NULL
domain	NULL
mediates	NULL
activation	NULL
of	NULL
HIV-1	NULL
by	NULL
the	NULL
regulatory	NULL
proteins	NULL
of	NULL
a	NULL
number	NULL
of	NULL
heterologous	NULL
viruses	NULL
,	NULL
including	NULL
the	NULL
ICPO	NULL
protein	NULL
of	NULL
herpes	NULL
simplex	NULL
virus	NULL
type	NULL
1	NULL
,	NULL
the	NULL
Ela	NULL
protein	NULL
of	NULL
adenovirus	NULL
,	NULL
and	NULL
the	NULL
Tax	NULL
protein	NULL
of	NULL
human	NULL
T-lymphotropic	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
41	NULL
,	NULL
64	NULL
)	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
HIV-1	NULL
replication	NULL
caused	NULL
by	NULL
the	NULL
cytokines	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
and	NULL
interleukin	NULL
1	NULL
,	NULL
specifically	NULL
implicated	NULL
in	NULL
reactivation	NULL
of	NULL
HIV-1	NULL
from	NULL
latency	NULL
in	NULL
astrocytes	NULL
(	NULL
61	NULL
)	NULL
,	NULL
is	NULL
also	NULL
mediated	NULL
by	NULL
the	NULL
«	NULL
xB	NULL
domain	NULL
(	NULL
43	NULL
,	NULL
45	NULL
)	NULL
.	NULL

The	NULL
importance	NULL
of	NULL
the	NULL
«	NULL
kB	NULL
domain	NULL
to	NULL
the	NULL
regulation	NULL
of	NULL
HIV-1	NULL
gene	NULL
expression	NULL
globally	NULL
,	NULL
and	NULL
,	NULL
specifically	NULL
,	NULL
the	NULL
involvement	NULL
of	NULL
the	NULL
«	NULL
kB	NULL
domain	NULL
in	NULL
mediating	NULL
transactivation	NULL
by	NULL
Tat	NULL
in	NULL
astrocytes	NULL
,	NULL
led	NULL
us	NULL
to	NULL
study	NULL
the	NULL
status	NULL
of	NULL
xB	NULL
transcription	NULL
factors	NULL
in	NULL
astrocytes	NULL
.	NULL

The	NULL
results	NULL
demonstrate	NULL
the	NULL
presence	NULL
of	NULL
kB-specific	NULL
binding	NULL
factors	NULL
in	NULL
human	NULL
glial	NULL
astrocytes	NULL
that	NULL
differ	NULL
from	NULL
prototypical	NULL
NF-	NULL
«	NULL
B	NULL
of	NULL
lymphocytes	NULL
.	NULL

Unlike	NULL
prototypical	NULL
NF-kB	NULL
,	NULL
the	NULL
form	NULL
of	NULL
kB	NULL
present	NULL
in	NULL
the	NULL
CNS	NULL
is	NULL
specifically	NULL
retained	NULL
on	NULL
an	NULL
HIV-1	NULL
Tat	NULL
affinity	NULL
column	NULL
,	NULL
indicating	NULL
either	NULL
a	NULL
direct	NULL
or	NULL
an	NULL
indirect	NULL
interaction	NULL
between	NULL
astrocyte-derived	NULL
kB	NULL
and	NULL
Tat	NULL
.	NULL

Astrocyte-derived	NULL
«	NULL
B-binding	NULL
factors	NULL
activate	NULL
transcription	NULL
of	NULL
HIV-1	NULL
in	NULL
vitro	NULL
in	NULL
a	NULL
promoter-specific	NULL
fashion	NULL
that	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
presence	NULL
of	NULL
«	NULL
B-binding	NULL
sites	NULL
.	NULL

Moreover	NULL
,	NULL
TAR-independent	NULL
transactivation	NULL
of	NULL
HIV-1	NULL
transcription	NULL
is	NULL
reproduced	NULL
in	NULL
vitro	NULL
and	NULL
is	NULL
found	NULL
to	NULL
be	NULL
dependent	NULL
on	NULL
an	NULL
astrocyte	NULL
factor	NULL
which	NULL
correlates	NULL
with	NULL
xB-binding	NULL
activity	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Oligonucleotides	NULL
and	NULL
in	NULL
vitro	NULL
transcription	NULL
templates	NULL
.	NULL

Templates	NULL
for	NULL
in	NULL
vitro	NULL
runoff	NULL
transcription	NULL
were	NULL
prepared	NULL
by	NULL
restriction	NULL
enzyme	NULL
digestion	NULL
of	NULL
expression	NULL
plasmids	NULL
p117/80	NULL
,	NULL
p117/3	NULL
,	NULL
and	NULL
80/3	NULL
(	NULL
containing	NULL
HIV-1	NULL
LTR	NULL
nucleotides	NULL
-117	NULL
to	NULL
+80	NULL
,	NULL
-117	NULL
to	NULL
+3	NULL
,	NULL
and	NULL
-80	NULL
to	NULL
+3	NULL
,	NULL
respectively	NULL
[	NULL
60	NULL
]	NULL
)	NULL
with	NULL
EcoRI	NULL
or	NULL
of	NULL
pAdMLP	NULL
(	NULL
containing	NULL
a	NULL
430-bp	NULL
Alul	NULL
fragment	NULL
of	NULL
pAd6	NULL
[	NULL
9	NULL
]	NULL
)	NULL
with	NULL
BamHI	NULL
.	NULL

Full-length	NULL
runoff	NULL
transcription	NULL
from	NULL
template	NULL
~117/+80	NULL
produces	NULL
a	NULL
transcript	NULL
of	NULL
356	NULL
nucleotides	NULL
.	NULL

Templates	NULL
-117/+3	NULL
and	NULL
-80/+3	NULL
produce	NULL
transcripts	NULL
of	NULL
279	NULL
nucleotides	NULL
.	NULL

Template	NULL
AdMLP	NULL
produces	NULL
a	NULL
transcript	NULL
of	NULL
375	NULL
nucleotides	NULL
.	NULL

Oligonucleotides	NULL
used	NULL
in	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSAs	NULL
)	NULL
and	NULL
in	NULL
vitro	NULL
transcription-competition	NULL
analysis	NULL
are	NULL
as	NULL
follows	NULL
(	NULL
single	NULL
strand	NULL
shown	NULL
only	NULL
)	NULL
:	NULL
5'-TCGA	NULL
CAGAGGGGACTTTCCGAGAGGC-3	NULL
'	NULL
(	NULL
wild-type	NULL
«	NULL
B	NULL
site	NULL
)	NULL
and	NULL
5-TCGACAGAGCTCACTTTCCGAGAGGC-3	NULL
'	NULL
(	NULL
mu-tant	NULL
xB	NULL
site	NULL
)	NULL
.	NULL

Cells	NULL
and	NULL
tissue	NULL
culture	NULL
.	NULL

U-87MG	NULL
cells	NULL
are	NULL
human	NULL
astrocytic	NULL
glioblastoma	NULL
cells	NULL
and	NULL
were	NULL
grown	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
media	NULL
(	NULL
Gibco	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
fetal	NULL
bovine	NULL
serum	NULL
(	NULL
Gibco	NULL
)	NULL
.	NULL

U-87MG	NULL
cells	NULL
,	NULL
originally	NULL
cloned	NULL
by	NULL
Ponten	NULL
et	NULL
al	NULL
.	NULL

(	NULL
46	NULL
)	NULL
in	NULL
1966	NULL
,	NULL
show	NULL
characteristic	NULL
markers	NULL
of	NULL
astrocytic	NULL
differentiation	NULL
and	NULL
are	NULL
available	NULL
from	NULL
the	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
.	NULL

The	NULL
biology	NULL
of	NULL
HIV-1	NULL
in	NULL
U-87MG	NULL
cells	NULL
has	NULL
been	NULL
studied	NULL
extensively	NULL
and	NULL
is	NULL
representative	NULL
of	NULL
behavior	NULL
in	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
astrocytes	NULL
(	NULL
6	NULL
,	NULL
14	NULL
,	NULL
15	NULL
,	NULL
46	NULL
,	NULL
58-60	NULL
)	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
(	NULL
Gibco	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
fetal	NULL
bovine	NULL
serum	NULL
.	NULL

For	NULL
induced	NULL
J.	NULL
ViroL..	NULL
cultures	NULL
,	NULL
50	NULL
ng	NULL
of	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
(	NULL
PMA	NULL
)	NULL
(	NULL
Sigma	NULL
)	NULL
per	NULL
ml	NULL
was	NULL
added	NULL
to	NULL
the	NULL
growth	NULL
media	NULL
1	NULL
,	NULL
3	NULL
,	NULL
6	NULL
,	NULL
12	NULL
,	NULL
or	NULL
20	NULL
h	NULL
prior	NULL
to	NULL
harvesting	NULL
the	NULL
cells	NULL
.	NULL

EMSA	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
U-87MG	NULL
glial	NULL
astrocytes	NULL
and	NULL
Jurkat	NULL
T	NULL
cells	NULL
for	NULL
use	NULL
in	NULL
EMSA	NULL
and	NULL
in	NULL
vitro	NULL
transcription	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
2	NULL
)	NULL
.	NULL

40,000	NULL
counts	NULL
of	NULL
*°P-end-labeled	NULL
wild-type	NULL
kB	NULL
oligonucleotide	NULL
was	NULL
incubated	NULL
with	NULL
8	NULL
ug	NULL
of	NULL
U-87MG	NULL
nuclear	NULL
extract	NULL
in	NULL
a	NULL
binding	NULL
buffer	NULL
consisting	NULL
of	NULL
10	NULL
mM	NULL
Tris	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
,	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
Na-EDTA	NULL
,	NULL
5	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
(	NULL
DTT	NULL
)	NULL
,	NULL
4	NULL
pg	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
,	NULL
0.5	NULL
mg	NULL
of	NULL
bovine	NULL
serum	NULL
albumin	NULL
(	NULL
BSA	NULL
)	NULL
per	NULL
ml	NULL
,	NULL
and	NULL
3	NULL
mM	NULL
GTP	NULL
.	NULL

Following	NULL
a	NULL
30-min	NULL
incubation	NULL
on	NULL
ice	NULL
,	NULL
the	NULL
resulting	NULL
complexes	NULL
were	NULL
resolved	NULL
on	NULL
a	NULL
low-ionic-strength	NULL
6	NULL
%	NULL
native	NULL
polyacryl-amide	NULL
gel	NULL
containing	NULL
6.7	NULL
mM	NULL
Tris	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
,	NULL
3.3	NULL
mM	NULL
Na-acetate	NULL
(	NULL
NaOAc	NULL
)	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
Na-EDTA	NULL
.	NULL

Electrophoresis	NULL
was	NULL
carried	NULL
out	NULL
at	NULL
4°C	NULL
at	NULL
a	NULL
constant	NULL
140	NULL
V	NULL
with	NULL
a	NULL
recirculating	NULL
buffer	NULL
.	NULL

The	NULL
gel	NULL
was	NULL
then	NULL
dried	NULL
and	NULL
autoradiographed	NULL
at	NULL
-70°C	NULL
with	NULL
an	NULL
instrument	NULL
fitted	NULL
with	NULL
an	NULL
intensifying	NULL
screen	NULL
.	NULL

For	NULL
competition	NULL
analysis	NULL
,	NULL
a	NULL
50-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
wild-type	NULL
or	NULL
mutant	NULL
oligonucleotide	NULL
was	NULL
added	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
mixture	NULL
.	NULL

Affinity	NULL
column	NULL
chromatography	NULL
.	NULL

A	NULL
400-pg	NULL
amount	NULL
of	NULL
purified	NULL
protein	NULL
(	NULL
Tat	NULL
or	NULL
BSA	NULL
)	NULL
was	NULL
dialyzed	NULL
against	NULL
coupling	NULL
buffer	NULL
containing	NULL
25	NULL
mM	NULL
HEPES	NULL
(	NULL
N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic	NULL
acid	NULL
)	NULL
buffer	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
20	NULL
mM	NULL
NaCl	NULL
,	NULL
5	NULL
mM	NULL
B-mercaptoethanol	NULL
,	NULL
and	NULL
10	NULL
%	NULL
glycerol	NULL
and	NULL
then	NULL
coupled	NULL
to	NULL
200	NULL
pl	NULL
of	NULL
washed	NULL
,	NULL
equilibrated	NULL
Affi-Gel	NULL
10	NULL
matrix	NULL
(	NULL
Bio-Rad	NULL
)	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
2.5	NULL
ml	NULL
overnight	NULL
at	NULL
4°C	NULL
.	NULL

A	NULL
400-pl	NULL
volume	NULL
of	NULL
U-87MG	NULL
or	NULL
Jurkat	NULL
T	NULL
whole-cell	NULL
extract	NULL
(	NULL
10	NULL
mg/ml	NULL
)	NULL
,	NULL
dialyzed	NULL
against	NULL
the	NULL
column	NULL
buffer	NULL
(	NULL
20	NULL
mM	NULL
HEPES	NULL
[	NULL
pH	NULL
7.9	NULL
]	NULL
,	NULL
50	NULL
mM	NULL
KCI	NULL
,	NULL
10	NULL
mM	NULL
MgClI	NULL
;	NULL
,	NULL
0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
20	NULL
%	NULL
glycerol	NULL
[	NULL
21	NULL
]	NULL
)	NULL
,	NULL
was	NULL
subjected	NULL
to	NULL
chromatography	NULL
at	NULL
4°C	NULL
at	NULL
a	NULL
flow	NULL
rate	NULL
of	NULL
1	NULL
ml/12.5	NULL
min	NULL
.	NULL

The	NULL
flowthrough	NULL
was	NULL
recycled	NULL
four	NULL
times	NULL
,	NULL
and	NULL
the	NULL
column	NULL
was	NULL
subsequently	NULL
washed	NULL
with	NULL
5	NULL
ml	NULL
of	NULL
column	NULL
buffer	NULL
.	NULL

Bound	NULL
proteins	NULL
were	NULL
step	NULL
eluted	NULL
with	NULL
KCI	NULL
concentrations	NULL
ranging	NULL
from	NULL
0.3	NULL
to	NULL
2.0	NULL
M.	NULL
Samples	NULL
of	NULL
the	NULL
flowthrough	NULL
,	NULL
the	NULL
first	NULL
400	NULL
pi	NULL
of	NULL
wash	NULL
buffer	NULL
,	NULL
the	NULL
final	NULL
400	NULL
pl	NULL
of	NULL
wash	NULL
buffer	NULL
,	NULL
and	NULL
each	NULL
of	NULL
the	NULL
salt	NULL
elution	NULL
fractions	NULL
were	NULL
dialyzed	NULL
against	NULL
dialysis	NULL
buffer	NULL
containing	NULL
50	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
6	NULL
mM	NULL
MgC	NULL
]	NULL
;	NULL
,	NULL
40	NULL
mM	NULL
(	NULL
NH	NULL
,	NULL
)	NULL
,	NULL
SO	NULL
,	NULL
,	NULL
0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
and	NULL
15	NULL
%	NULL
glycerol	NULL
and	NULL
analyzed	NULL
for	NULL
kB-binding	NULL
activity	NULL
by	NULL
EMSA	NULL
.	NULL

Samples	NULL
of	NULL
all	NULL
fractions	NULL
were	NULL
examined	NULL
by	NULL
silver	NULL
staining	NULL
of	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
gels	NULL
,	NULL
which	NULL
demonstrated	NULL
that	NULL
all	NULL
fractions	NULL
retained	NULL
full	NULL
integrity	NULL
(	NULL
no	NULL
degradation	NULL
detectable	NULL
)	NULL
.	NULL

No	NULL
gross	NULL
differences	NULL
were	NULL
observed	NULL
between	NULL
Tat	NULL
and	NULL
BSA	NULL
fractions	NULL
by	NULL
silver	NULL
stain	NULL
.	NULL

In	NULL
vitro	NULL
transcription	NULL
analysis	NULL
.	NULL

To	NULL
analyze	NULL
basal	NULL
transcription	NULL
,	NULL
50	NULL
to	NULL
100	NULL
ng	NULL
of	NULL
each	NULL
template	NULL
was	NULL
incubated	NULL
with	NULL
1.3	NULL
mM	NULL
ATP	NULL
,	NULL
1.3	NULL
mM	NULL
GTP	NULL
,	NULL
1.3	NULL
mM	NULL
CTP	NULL
,	NULL
20	NULL
pCi	NULL
of	NULL
[	NULL
«	NULL
-	NULL
``	NULL
``	NULL
P	NULL
]	NULL
JUTP	NULL
(	NULL
400	NULL
Ci/mmol	NULL
)	NULL
,	NULL
and	NULL
7	NULL
pul	NULL
of	NULL
HeLa	NULL
whole-cell	NULL
extract	NULL
in	NULL
a	NULL
reaction	NULL
volume	NULL
at	NULL
30°C	NULL
for	NULL
1	NULL
h.	NULL
HeLa	NULL
whole-cell	NULL
extract	NULL
was	NULL
prepared	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
35	NULL
)	NULL
.	NULL

The	NULL
order	NULL
of	NULL
addition	NULL
of	NULL
the	NULL
components	NULL
of	NULL
the	NULL
transcription	NULL
reaction	NULL
mixture	NULL
was	NULL
consistently	NULL
as	NULL
follows	NULL
:	NULL
(	NULL
i	NULL
)	NULL
template	NULL
DNA	NULL
[	NULL
and	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
when	NULL
appropriate	NULL
]	NULL
,	NULL
(	NULL
ii	NULL
)	NULL
nucleoside	NULL
triphosphates	NULL
,	NULL
(	NULL
iii	NULL
)	NULL
transcription	NULL
extract	NULL
,	NULL
and	NULL
(	NULL
iv	NULL
)	NULL
[	NULL
«	NULL
-	NULL
``	NULL
``	NULL
P	NULL
]	NULL
JUTP	NULL
.	NULL

Transcription	NULL
reactions	NULL
were	NULL
stopped	NULL
by	NULL
addition	NULL
of	NULL
200	NULL
pl	NULL
of	NULL
stop	NULL
solution	NULL
containing	NULL
10	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
1	NULL
%	NULL
SDS	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
and	NULL
50	NULL
mg	NULL
of	NULL
tRNA	NULL
per	NULL
ml	NULL
and	NULL
200	NULL
pl	NULL
of	NULL
phenol	NULL
.	NULL

This	NULL
mixture	NULL
was	NULL
gently	NULL
rocked	NULL
for	NULL
5	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
extracted	NULL
three	NULL
to	NULL
five	NULL
times	NULL
with	NULL
phenol-chloroform	NULL
and	NULL
once	NULL
with	NULL
chloroform	NULL
,	NULL
and	NULL
ethanol	NULL
precipitated	NULL
with	NULL
0.3	NULL
M	NULL
NaOAc	NULL
on	NULL
dry	NULL
ice	NULL
.	NULL

After	NULL
centrifugation	NULL
,	NULL
the	NULL
RNA	NULL
was	NULL
resuspended	NULL
in	NULL
gel	NULL
loading	NULL
buffer	NULL
(	NULL
90	NULL
%	NULL
deionized	NULL
formamide	NULL
,	NULL
5	NULL
%	NULL
Tris-borate-EDTA	NULL
,	NULL
and	NULL
0.5	NULL
%	NULL
bromophenol	NULL
blue	NULL
)	NULL
and	NULL
analyzed	NULL
by	NULL
electrophoresis	NULL
on	NULL
a	NULL
denaturing	NULL
acrylamide-urea	NULL
gel	NULL
.	NULL

To	NULL
analyze	NULL
the	NULL
influence	NULL
of	NULL
PMA-stimulated	NULL
U-87MG	NULL
nuclear	NULL
extracts	NULL
on	NULL
transcription	NULL
,	NULL
VoL	NULL
.	NULL

68	NULL
,	NULL
1994	NULL
A	NULL
.	NULL

B.	NULL
PMA	NULL
(	NULL
hr	NULL
)	NULL
:	NULL
0	NULL
1	NULL
3	NULL
6	NULL
12	NULL
20	NULL
wos	NULL
gon	NULL
ws	NULL
gome	NULL
qerpgeme	NULL
-	NULL
HHHBN	NULL
:	NULL
=	NULL
at	NULL
-	NULL
»	NULL
bo	NULL
y	NULL
$	NULL
n	NULL
PMA	NULL
(	NULL
hr	NULL
)	NULL
:	NULL
O	NULL
7	NULL
CNS-DERIVED	NULL
«	NULL
B	NULL
REGULATION	NULL
OF	NULL
HIV-1	NULL
EXPRESSION	NULL
3973	NULL
CS	NULL
p	NULL
a	NULL
AY	NULL
$	NULL
f	NULL
tans	NULL
wo	NULL
!	NULL

qP	NULL
ft	NULL
Comd	NULL
B	NULL
-	NULL
»	NULL
<	NULL
-	NULL
B	NULL
or	NULL
-	NULL
»	NULL
<	NULL
—	NULL
B2	NULL
6	NULL
``	NULL
_	NULL
i	NULL
one	NULL
``	NULL
3	NULL
3	NULL
4	NULL
:	NULL
S	NULL
6	NULL
7	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Astrocytes	NULL
express	NULL
xB-binding	NULL
activity	NULL
that	NULL
is	NULL
induced	NULL
in	NULL
a	NULL
bimodal	NULL
fashion	NULL
and	NULL
differs	NULL
from	NULL
the	NULL
NF-kB	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
EMSA	NULL
demonstrating	NULL
kB-binding	NULL
activity	NULL
(	NULL
designated	NULL
«	NULL
and	NULL
B	NULL
)	NULL
of	NULL
unstimulated	NULL
U-87MG	NULL
cells	NULL
and	NULL
cells	NULL
stimulated	NULL
with	NULL
PMA	NULL
for	NULL
1	NULL
,	NULL
3	NULL
,	NULL
6	NULL
,	NULL
12	NULL
,	NULL
or	NULL
20	NULL
h	NULL
as	NULL
indicated	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Specificity	NULL
of	NULL
astrocytic	NULL
xB-binding	NULL
activity	NULL
.	NULL

Competition	NULL
analysis	NULL
was	NULL
performed	NULL
by	NULL
including	NULL
a	NULL
50-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
wild-type	NULL
B	NULL
oligonucleotide	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
6	NULL
)	NULL
or	NULL
mutant	NULL
«	NULL
B	NULL
oligonucleotide	NULL
(	NULL
5-TCGACAGAGCTCACTTTCCGAGAGGC-3	NULL
'	NULL
)	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
7	NULL
)	NULL
in	NULL
the	NULL
binding	NULL
reaction	NULL
mixture	NULL
.	NULL

Lanes	NULL
:	NULL
1	NULL
,	NULL
unstimulated	NULL
U-87MG	NULL
nuclear	NULL
extract	NULL
;	NULL
2	NULL
to	NULL
4	NULL
,	NULL
3-h	NULL
PMA-stimulated	NULL
U-87MG	NULL
nuclear	NULL
extract	NULL
;	NULL
5	NULL
to	NULL
7	NULL
,	NULL
20-h	NULL
PMA-stimulated	NULL
U-87MG	NULL
nuclear	NULL
extract	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Astrocytic	NULL
xB-binding	NULL
activity	NULL
differs	NULL
from	NULL
prototypical	NULL
NF-	NULL
«	NULL
B	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

A	NULL
comparison	NULL
of	NULL
the	NULL
migration	NULL
of	NULL
xB	NULL
complexes	NULL
formed	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
with	NULL
that	NULL
of	NULL
those	NULL
formed	NULL
in	NULL
U-87MG	NULL
cells	NULL
is	NULL
shown	NULL
.	NULL

Lanes	NULL
:	NULL
1	NULL
,	NULL
Jurkat	NULL
T	NULL
cells	NULL
;	NULL
2	NULL
,	NULL
probe	NULL
;	NULL
3	NULL
,	NULL
U-87MG	NULL
cells	NULL
.	NULL

To	NULL
reveal	NULL
the	NULL
B1	NULL
and	NULL
B2	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
,	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
20	NULL
h	NULL
with	NULL
PMA	NULL
before	NULL
nuclear	NULL
extract	NULL
preparation	NULL
.	NULL

the	NULL
reaction	NULL
mixtures	NULL
,	NULL
containing	NULL
suboptimum	NULL
concentrations	NULL
of	NULL
the	NULL
template	NULL
DNAs	NULL
(	NULL
20	NULL
ng	NULL
)	NULL
and	NULL
4	NULL
pl	NULL
of	NULL
HeLa	NULL
whole-cell	NULL
extract	NULL
,	NULL
were	NULL
supplemented	NULL
with	NULL
2	NULL
pl	NULL
of	NULL
the	NULL
appropriate	NULL
astrocytic	NULL
nuclear	NULL
extract	NULL
.	NULL

Titration	NULL
of	NULL
the	NULL
template	NULL
indicated	NULL
that	NULL
25	NULL
ng	NULL
provided	NULL
an	NULL
optimal	NULL
basal	NULL
activity	NULL
for	NULL
analysis	NULL
of	NULL
transcriptional	NULL
activation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

For	NULL
the	NULL
in	NULL
vitro	NULL
transcription	NULL
competition	NULL
experiments	NULL
,	NULL
the	NULL
glial	NULL
nuclear	NULL
extracts	NULL
were	NULL
preincubated	NULL
with	NULL
1	NULL
pg	NULL
of	NULL
either	NULL
wild-type	NULL
or	NULL
mutant	NULL
«	NULL
B	NULL
oligonucleotide	NULL
for	NULL
15	NULL
min	NULL
on	NULL
ice	NULL
before	NULL
being	NULL
added	NULL
to	NULL
the	NULL
transcription	NULL
reaction	NULL
mixture	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
in	NULL
vitro	NULL
transcription	NULL
competition	NULL
reaction	NULL
mixtures	NULL
contained	NULL
only	NULL
15	NULL
ug	NULL
of	NULL
template	NULL
DNA	NULL
and	NULL
were	NULL
supplemented	NULL
with	NULL
0.5	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
.	NULL

For	NULL
the	NULL
in	NULL
vitro	NULL
transcription	NULL
transactivation	NULL
experiments	NULL
,	NULL
the	NULL
transcription	NULL
extracts	NULL
were	NULL
preincubated	NULL
with	NULL
1	NULL
wM	NULL
synthetic	NULL
Tat	NULL
protein	NULL
for	NULL
15	NULL
min	NULL
on	NULL
ice	NULL
.	NULL

Synthetic	NULL
Tat	NULL
protein	NULL
(	NULL
amino	NULL
acids	NULL
1	NULL
to	NULL
86	NULL
)	NULL
,	NULL
a	NULL
generous	NULL
gift	NULL
of	NULL
S.	NULL
A.	NULL
Khan	NULL
,	NULL
Wistar	NULL
Institute	NULL
,	NULL
Philadelphia	NULL
,	NULL
Pa.	NULL
,	NULL
was	NULL
stored	NULL
lyophilized	NULL
at	NULL
-70°C	NULL
.	NULL

For	NULL
use	NULL
,	NULL
Tat	NULL
was	NULL
dissolved	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
1	NULL
mg/ml	NULL
in	NULL
20	NULL
mM	NULL
HEPES-KOH	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
-20	NULL
%	NULL
glycerol	NULL
(	NULL
vol/	NULL
vol	NULL
)	NULL
-100	NULL
mM	NULL
KCI-O0.2	NULL
mM	NULL
EDTA-1	NULL
mM	NULL
DTT	NULL
and	NULL
degassed	NULL
with	NULL
N	NULL
;	NULL
.	NULL

In	NULL
quantitation	NULL
,	NULL
densitometry	NULL
results	NULL
were	NULL
normalized	NULL
for	NULL
RNA	NULL
recovery	NULL
and	NULL
gel	NULL
loading	NULL
by	NULL
comparison	NULL
with	NULL
a	NULL
reference	NULL
band	NULL
labeled	NULL
R.	NULL
This	NULL
product	NULL
is	NULL
transcription	NULL
independent	NULL
and	NULL
probably	NULL
represents	NULL
tRNA	NULL
labeled	NULL
with	NULL
[	NULL
°°P	NULL
]	NULL
UTP	NULL
.	NULL

RESULTS	NULL
Human	NULL
astrocytes	NULL
contain	NULL
B-binding	NULL
activity	NULL
.	NULL

Observation	NULL
that	NULL
the	NULL
HIV-1	NULL
«	NULL
B	NULL
domain	NULL
mediated	NULL
cell-specific	NULL
Tat	NULL
transactivation	NULL
prompted	NULL
an	NULL
analysis	NULL
of	NULL
kB-binding	NULL
factors	NULL
from	NULL
astrocytes	NULL
(	NULL
U-87MG	NULL
,	NULL
an	NULL
astrocytic	NULL
glioblastoma	NULL
cell	NULL
line	NULL
,	NULL
is	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

EMSA	NULL
using	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
U-87MG	NULL
astrocytes	NULL
reveals	NULL
two	NULL
complexes	NULL
,	NULL
designated	NULL
a	NULL
and	NULL
B	NULL
,	NULL
which	NULL
form	NULL
with	NULL
an	NULL
oligonucleotide	NULL
probe	NULL
containing	NULL
the	NULL
HIV-1	NULL
«	NULL
kB	NULL
sequence	NULL
(	NULL
GGGACTTTCC	NULL
)	NULL
.	NULL

A	NULL
biphasic	NULL
pattern	NULL
of	NULL
induction	NULL
in	NULL
«	NULL
B	NULL
complex	NULL
formation	NULL
is	NULL
observed	NULL
upon	NULL
treatment	NULL
with	NULL
the	NULL
mitogen	NULL
PMA	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
PMA	NULL
treatment	NULL
,	NULL
both	NULL
the	NULL
a	NULL
and	NULL
B	NULL
complexes	NULL
are	NULL
present	NULL
at	NULL
a	NULL
low	NULL
,	NULL
basal	NULL
level	NULL
with	NULL
a	NULL
comparable	NULL
ratio	NULL
of	NULL
«	NULL
and	NULL
B	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

Appearance	NULL
of	NULL
the	NULL
«	NULL
complex	NULL
is	NULL
substantially	NULL
induced	NULL
at	NULL
1	NULL
to	NULL
3	NULL
h	NULL
after	NULL
PMA	NULL
stimulation	NULL
,	NULL
while	NULL
the	NULL
B	NULL
complex	NULL
is	NULL
slightly	NULL
induced	NULL
,	NULL
resulting	NULL
in	NULL
a	NULL
dramatic	NULL
increase	NULL
in	NULL
a	NULL
complex	NULL
relative	NULL
to	NULL
B	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

After	NULL
6	NULL
to	NULL
12	NULL
h	NULL
of	NULL
continuous	NULL
stimulation	NULL
by	NULL
PMA	NULL
,	NULL
the	NULL
«	NULL
/B	NULL
ratio	NULL
returns	NULL
to	NULL
the	NULL
levels	NULL
observed	NULL
in	NULL
nontreated	NULL
cells	NULL
,	NULL
although	NULL
the	NULL
quantity	NULL
of	NULL
both	NULL
complexes	NULL
remains	NULL
elevated	NULL
above	NULL
basal	NULL
levels	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

After	NULL
20	NULL
h	NULL
of	NULL
PMA	NULL
stimulation	NULL
,	NULL
the	NULL
B	NULL
complex	NULL
is	NULL
greatly	NULL
induced	NULL
,	NULL
while	NULL
the	NULL
a	NULL
complex	NULL
remains	NULL
unaltered	NULL
,	NULL
resulting	NULL
in	NULL
a	NULL
dramatic	NULL
increase	NULL
in	NULL
the	NULL
ratio	NULL
of	NULL
B	NULL
complex	NULL
relative	NULL
to	NULL
«	NULL
,	NULL
an	NULL
inversion	NULL
of	NULL
the	NULL
previous	NULL
ratio	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

Both	NULL
the	NULL
a	NULL
and	NULL
B	NULL
complexes	NULL
were	NULL
determined	NULL
to	NULL
represent	NULL
a	NULL
specific	NULL
interaction	NULL
with	NULL
the	NULL
kB	NULL
sequence	NULL
by	NULL
competition	NULL
analysis	NULL
.	NULL

Formation	NULL
of	NULL
the	NULL
a	NULL
complex	NULL
,	NULL
induced	NULL
upon	NULL
stimulation	NULL
of	NULL
U-87MG	NULL
cells	NULL
with	NULL
PMA	NULL
for	NULL
3	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
was	NULL
blocked	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
50-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
wild-type	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
but	NULL
not	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
mutant	NULL
«	NULL
B-binding	NULL
site	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
formation	NULL
of	NULL
the	NULL
B	NULL
complex	NULL
,	NULL
induced	NULL
upon	NULL
stimulation	NULL
of	NULL
U-87MG	NULL
cells	NULL
with	NULL
PMA	NULL
for	NULL
20	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
was	NULL
blocked	NULL
by	NULL
a	NULL
50-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
,	NULL
wild-type	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
but	NULL
not	NULL
by	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
mutant	NULL
kB-binding	NULL
site	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

Astrocyte-derived	NULL
B-binding	NULL
factors	NULL
differ	NULL
from	NULL
those	NULL
observed	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

The	NULL
prototypical	NULL
NF-kB	NULL
induced	NULL
by	NULL
PMA	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
appears	NULL
as	NULL
two	NULL
complexes	NULL
that	NULL
have	NULL
been	NULL
previously	NULL
designated	NULL
B1	NULL
and	NULL
B2	NULL
(	NULL
10	NULL
)	NULL
.	NULL

The	NULL
a	NULL
complex	NULL
of	NULL
U-87MG	NULL
astrocytes	NULL
comigrates	NULL
with	NULL
the	NULL
B1	NULL
complex	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
3	NULL
)	NULL
and	NULL
is	NULL
induced	NULL
with	NULL
kinetics	NULL
similar	NULL
to	NULL
those	NULL
reported	NULL
for	NULL
B1	NULL
following	NULL
stimulation	NULL
with	NULL
PMA	NULL
(	NULL
38	NULL
)	NULL
.	NULL

The	NULL
B1	NULL
complex	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
consists	NULL
of	NULL
3974	NULL
TAYLOR	NULL
ET	NULL
AL	NULL
.	NULL

1	NULL
2	NULL
3	NULL
4	NULL
J.	NULL
Viror	NULL
.	NULL

te	NULL
to	NULL
4	NULL
in	NULL
6	NULL
7	NULL
-	NULL
$	NULL
9	NULL
6	NULL
7	NULL
8	NULL
9	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Retention	NULL
of	NULL
astrocyte-derived	NULL
«	NULL
B	NULL
activity	NULL
on	NULL
a	NULL
Tat	NULL
affinity	NULL
column	NULL
.	NULL

(	NULL
A	NULL
)	NULL
EMSA	NULL
analysis	NULL
of	NULL
PMA-stimulated	NULL
U-87MG	NULL
whole-cell	NULL
extract	NULL
following	NULL
chromatography	NULL
on	NULL
a	NULL
Tat	NULL
affinity	NULL
column	NULL
.	NULL

First	NULL
wash	NULL
,	NULL
recycled	NULL
flowthrough	NULL
diluted	NULL
with	NULL
column	NULL
buffer	NULL
;	NULL
Last	NULL
wash	NULL
,	NULL
the	NULL
final	NULL
400	NULL
pl	NULL
of	NULL
a	NULL
5-ml	NULL
wash	NULL
with	NULL
column	NULL
buffer	NULL
.	NULL

Further	NULL
fractions	NULL
were	NULL
step	NULL
eluted	NULL
from	NULL
the	NULL
column	NULL
with	NULL
the	NULL
indicated	NULL
concentrations	NULL
of	NULL
KCl	NULL
.	NULL

(	NULL
B	NULL
)	NULL
EMSA	NULL
analysis	NULL
of	NULL
PMA-stimulated	NULL
U-87MG	NULL
whole-cell	NULL
extract	NULL
following	NULL
chromatography	NULL
on	NULL
a	NULL
BSA	NULL
affinity	NULL
column	NULL
.	NULL

(	NULL
C	NULL
)	NULL
EMSA	NULL
analysis	NULL
of	NULL
PMA-stimulated	NULL
Jurkat-T	NULL
whole-cell	NULL
extract	NULL
following	NULL
chromatography	NULL
on	NULL
a	NULL
Tat	NULL
affinity	NULL
column	NULL
.	NULL

proteins	NULL
of	NULL
75	NULL
,	NULL
86	NULL
,	NULL
and	NULL
50	NULL
to	NULL
55	NULL
kDa	NULL
,	NULL
believed	NULL
to	NULL
represent	NULL
p65	NULL
,	NULL
c-Rel	NULL
,	NULL
and	NULL
p50	NULL
,	NULL
respectively	NULL
(	NULL
38	NULL
)	NULL
.	NULL

The	NULL
B	NULL
complex	NULL
of	NULL
U-87MG	NULL
astrocytes	NULL
migrates	NULL
very	NULL
slowly	NULL
in	NULL
the	NULL
native	NULL
gel	NULL
,	NULL
suggestive	NULL
of	NULL
a	NULL
very	NULL
large	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

A	NULL
similarly	NULL
large	NULL
complex	NULL
which	NULL
migrates	NULL
more	NULL
slowly	NULL
than	NULL
NF-kB	NULL
,	NULL
coincidentally	NULL
termed	NULL
BETA	NULL
,	NULL
was	NULL
previously	NULL
observed	NULL
in	NULL
astrocytes	NULL
and	NULL
neurons	NULL
(	NULL
31	NULL
)	NULL
and	NULL
has	NULL
also	NULL
been	NULL
observed	NULL
in	NULL
mouse	NULL
and	NULL
human	NULL
fetal	NULL
brain	NULL
nuclear	NULL
extracts	NULL
(	NULL
unpublished	NULL
observation	NULL
)	NULL
.	NULL

The	NULL
induction	NULL
kinetics	NULL
of	NULL
B	NULL
complex	NULL
suggest	NULL
that	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
may	NULL
precede	NULL
the	NULL
formation	NULL
of	NULL
this	NULL
complex	NULL
.	NULL

No	NULL
complex	NULL
of	NULL
comparable	NULL
migration	NULL
is	NULL
observed	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
suggesting	NULL
that	NULL
astrocytes	NULL
contain	NULL
additional	NULL
,	NULL
or	NULL
perhaps	NULL
novel	NULL
,	NULL
«	NULL
B-binding	NULL
factors	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

The	NULL
B2	NULL
complex	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
which	NULL
consists	NULL
solely	NULL
of	NULL
50-	NULL
to	NULL
55-kDa	NULL
proteins	NULL
and	NULL
probably	NULL
represents	NULL
a	NULL
homodimer	NULL
of	NULL
p50	NULL
(	NULL
38	NULL
)	NULL
,	NULL
does	NULL
not	NULL
appear	NULL
in	NULL
astrocytic	NULL
extracts	NULL
,	NULL
demonstrating	NULL
further	NULL
heterogeneity	NULL
between	NULL
kB-binding	NULL
factors	NULL
in	NULL
U-87MG	NULL
astrocytes	NULL
and	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
astrocytic	NULL
xB-binding	NULL
factors	NULL
differ	NULL
from	NULL
prototypical	NULL
NF-kB	NULL
in	NULL
susceptibility	NULL
to	NULL
dissociation	NULL
by	NULL
oxidation	NULL
,	NULL
salts	NULL
,	NULL
and	NULL
treatment	NULL
with	NULL
detergents	NULL
(	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

Astrocyte-derived	NULL
xB	NULL
is	NULL
specifically	NULL
retained	NULL
on	NULL
an	NULL
HIV-1	NULL
Tat	NULL
affinity	NULL
column	NULL
,	NULL
while	NULL
prototypical	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
not	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
potential	NULL
interaction	NULL
between	NULL
kB-binding	NULL
factors	NULL
and	NULL
Tat	NULL
,	NULL
whole-cell	NULL
extract	NULL
prepared	NULL
from	NULL
PMA-stimulated	NULL
U-87MG	NULL
and	NULL
Jurkat	NULL
T	NULL
cells	NULL
was	NULL
subjected	NULL
to	NULL
chromatography	NULL
over	NULL
an	NULL
HIV-1	NULL
Tat	NULL
affinity	NULL
column	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
both	NULL
«	NULL
and	NULL
B	NULL
complexes	NULL
from	NULL
U-87MG	NULL
cells	NULL
can	NULL
be	NULL
observed	NULL
in	NULL
the	NULL
loaded	NULL
extract	NULL
,	NULL
as	NULL
well	NULL
as	NULL
in	NULL
the	NULL
flowthrough	NULL
and	NULL
the	NULL
first	NULL
washing	NULL
fraction	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
lanes	NULL
1	NULL
to	NULL
3	NULL
)	NULL
.	NULL

No	NULL
kB-binding	NULL
activity	NULL
is	NULL
observed	NULL
in	NULL
the	NULL
last	NULL
washing	NULL
fraction	NULL
,	NULL
which	NULL
contains	NULL
very	NULL
little	NULL
protein	NULL
as	NULL
determined	NULL
by	NULL
silver	NULL
staining	NULL
(	NULL
unpublished	NULL
observation	NULL
)	NULL
.	NULL

Band	NULL
shift	NULL
analysis	NULL
of	NULL
salt	NULL
elution	NULL
fractions	NULL
demonstrates	NULL
that	NULL
«	NULL
B-binding	NULL
activity	NULL
,	NULL
in	NULL
the	NULL
form	NULL
of	NULL
a	NULL
B	NULL
complex	NULL
,	NULL
retained	NULL
on	NULL
the	NULL
Tat	NULL
column	NULL
is	NULL
released	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
0.3	NULL
to	NULL
0.5	NULL
M	NULL
KCI	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

The	NULL
a	NULL
complex	NULL
,	NULL
in	NULL
contrast	NULL
,	NULL
is	NULL
not	NULL
retained	NULL
by	NULL
the	NULL
Tat	NULL
column	NULL
,	NULL
suggesting	NULL
a	NULL
structural	NULL
difference	NULL
between	NULL
these	NULL
two	NULL
astrocyte-derived	NULL
«	NULL
B-binding	NULL
activities	NULL
.	NULL

To	NULL
examine	NULL
binding	NULL
specificity	NULL
,	NULL
U-87MG	NULL
whole-cell	NULL
extract	NULL
was	NULL
subjected	NULL
to	NULL
chromatography	NULL
over	NULL
a	NULL
control	NULL
affinity	NULL
column	NULL
containing	NULL
BSA	NULL
.	NULL

As	NULL
can	NULL
be	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
«	NULL
B-binding	NULL
activity	NULL
is	NULL
not	NULL
retained	NULL
on	NULL
a	NULL
BSA	NULL
affinity	NULL
column	NULL
.	NULL

In	NULL
a	NULL
parallel	NULL
experiment	NULL
,	NULL
whole-cell	NULL
extract	NULL
from	NULL
PMA-stimulated	NULL
Jurkat	NULL
T	NULL
cells	NULL
was	NULL
subjected	NULL
to	NULL
chromatogra-	NULL
Vor	NULL
.	NULL

68	NULL
,	NULL
1994	NULL
A	NULL
417	NULL
-80	NULL
Spi	NULL
+1	NULL
EcoRI	NULL
a	NULL
_	NULL
sy	NULL
T	NULL
§	NULL
-117/+80	NULL
(	NULL
+TAR	NULL
)	NULL
``	NULL
I	NULL
57	NULL
ﬂ	NULL
.	NULL
)	NULL

Spi	NULL
+1	NULL
En	NULL
?	NULL

!	NULL

“	NULL
-117/+3	NULL
(	NULL
-TAR	NULL
)	NULL
E	NULL
B.	NULL
Template	NULL
:	NULL
Tart	NULL
Ta	NULL
``	NULL
Tart	NULL
Tar	NULL
``	NULL
c-amanitin	NULL
:	NULL
=-	NULL
--	NULL
+	NULL
+	NULL
tod	NULL
8	NULL
€	NULL
phy	NULL
over	NULL
the	NULL
Tat	NULL
affinity	NULL
column	NULL
and	NULL
the	NULL
control	NULL
BSA	NULL
affinity	NULL
column	NULL
.	NULL

All	NULL
of	NULL
the	NULL
prototypical	NULL
NF-kB	NULL
from	NULL
these	NULL
cells	NULL
was	NULL
found	NULL
in	NULL
the	NULL
flowthrough	NULL
and	NULL
early	NULL
wash	NULL
steps	NULL
,	NULL
as	NULL
was	NULL
the	NULL
«	NULL
complex	NULL
from	NULL
U-87MG	NULL
cells	NULL
,	NULL
suggesting	NULL
that	NULL
these	NULL
factors	NULL
are	NULL
unable	NULL
to	NULL
bind	NULL
to	NULL
Tat	NULL
and	NULL
be	NULL
retained	NULL
on	NULL
the	NULL
Tat	NULL
affinity	NULL
column	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

Band	NULL
shift	NULL
analysis	NULL
of	NULL
the	NULL
Jurkat	NULL
extract	NULL
on	NULL
the	NULL
control	NULL
BSA	NULL
showed	NULL
no	NULL
«	NULL
kB-binding	NULL
activity	NULL
in	NULL
the	NULL
salt-eluted	NULL
fractions	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
the	NULL
B	NULL
complex	NULL
derived	NULL
from	NULL
astrocytes	NULL
to	NULL
bind	NULL
Tat	NULL
further	NULL
distinguishes	NULL
this	NULL
xB	NULL
activity	NULL
from	NULL
prototypical	NULL
NF-kB	NULL
and	NULL
promotes	NULL
this	NULL
activity	NULL
as	NULL
a	NULL
candidate	NULL
for	NULL
mediating	NULL
TAR-independent	NULL
transactivation	NULL
.	NULL

Transcriptional	NULL
transactivation	NULL
correlates	NULL
with	NULL
«	NULL
B-binding	NULL
activity	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
influence	NULL
of	NULL
astrocytic	NULL
nuclear	NULL
factors	NULL
on	NULL
HIV-1	NULL
transcription	NULL
,	NULL
a	NULL
cell-free	NULL
in	NULL
vitro	NULL
transcription	NULL
system	NULL
was	NULL
established	NULL
by	NULL
using	NULL
HeLa	NULL
whole-cell	NULL
extract	NULL
.	NULL

Templates	NULL
for	NULL
runoff	NULL
transcription	NULL
were	NULL
generated	NULL
by	NULL
EcoRI	NULL
digests	NULL
of	NULL
LTR-chloramphenicol	NULL
acetyltransferase	NULL
constructs	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

Template	NULL
-117/+80	NULL
contains	NULL
the	NULL
HIV-1	NULL
LTR	NULL
sequences	NULL
from	NULL
-117	NULL
to	NULL
+80	NULL
relative	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
,	NULL
which	NULL
includes	NULL
the	NULL
«	NULL
B	NULL
domain	NULL
(	NULL
-	NULL
105	NULL
to	NULL
-80	NULL
)	NULL
,	NULL
a	NULL
GC-rich	NULL
Sp1-binding	NULL
domain	NULL
(	NULL
-47	NULL
to	NULL
-79	NULL
)	NULL
,	NULL
a	NULL
canonical	NULL
TATA	NULL
sequence	NULL
,	NULL
and	NULL
80	NULL
nucleotides	NULL
of	NULL
the	NULL
HIV-1	NULL
leader	NULL
sequence	NULL
encoding	NULL
TAR	NULL
.	NULL

Correct	NULL
transcription	NULL
initiation	NULL
on	NULL
template	NULL
-	NULL
117/+80	NULL
gener-	NULL
CNS-DERIVED	NULL
«	NULL
B	NULL
REGULATION	NULL
OF	NULL
HIV-1	NULL
EXPRESSION	NULL
3975	NULL
C.	NULL
PMA	NULL
(	NULL
hr	NULL
)	NULL
:	NULL
-	NULL
-	NULL
0	NULL
0	NULL
0	NULL
10°	NULL
3°	NULL
60	NULL
120	NULL
20	NULL
-117/+80	NULL
-	NULL
»	NULL
117/43	NULL
-	NULL
>	NULL
»	NULL
WW	NULL
m	NULL
-80/+3	NULL
-	NULL
»	NULL
Ad	NULL
MLP	NULL
-	NULL
»	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

(	NULL
A	NULL
)	NULL
HIV-1	NULL
LTR	NULL
templates	NULL
used	NULL
for	NULL
in	NULL
vitro	NULL
transcription	NULL
.	NULL

(	NULL
B	NULL
)	NULL
In	NULL
vitro	NULL
transcription	NULL
of	NULL
templates	NULL
-117/+80	NULL
(	NULL
Tar	NULL
'	NULL
)	NULL
and	NULL
-117/+3	NULL
(	NULL
Tar	NULL
'	NULL
)	NULL
.	NULL

Lanes	NULL
:	NULL
1	NULL
,	NULL
template	NULL
-117/+80	NULL
generates	NULL
a	NULL
runoff	NULL
transcript	NULL
of	NULL
356	NULL
nucleotides	NULL
(	NULL
thin	NULL
arrow	NULL
)	NULL
;	NULL
2	NULL
,	NULL
template	NULL
-117/+3	NULL
generates	NULL
a	NULL
runoff	NULL
transcript	NULL
of	NULL
279	NULL
nucleotides	NULL
(	NULL
thick	NULL
arrow	NULL
)	NULL
.	NULL

The	NULL
reaction	NULL
mixtures	NULL
in	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
contained	NULL
«	NULL
-amanitin	NULL
(	NULL
0.5	NULL
pg/ml	NULL
)	NULL
and	NULL
template	NULL
-117/	NULL
+80	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
and	NULL
template	NULL
-117/+3	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

M.	NULL
marker	NULL
.	NULL

-	NULL
and	NULL
+	NULL
indicate	NULL
absence	NULL
and	NULL
presence	NULL
,	NULL
respectively	NULL
,	NULL
of	NULL
a-amanitin	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Nuclear	NULL
factors	NULL
from	NULL
U-87MG	NULL
astrocytes	NULL
stimulate	NULL
HIV-1	NULL
transcription	NULL
.	NULL

Shown	NULL
is	NULL
in	NULL
vitro	NULL
transcription	NULL
of	NULL
the	NULL
appropriate	NULL
template	NULL
(	NULL
-	NULL
117/+80	NULL
,	NULL
-117/+3	NULL
,	NULL
=-80/+3	NULL
,	NULL
or	NULL
AdMLP	NULL
)	NULL
in	NULL
HeLa	NULL
transcription	NULL
extract	NULL
alone	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
(	NULL
-	NULL
)	NULL
,	NULL
HeLa	NULL
transcription	NULL
extract	NULL
supplemented	NULL
with	NULL
unstimulated	NULL
U-87MG	NULL
nuclear	NULL
extract	NULL
(	NULL
0	NULL
)	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
or	NULL
HeLa	NULL
transcription	NULL
extract	NULL
supplemented	NULL
with	NULL
nuclear	NULL
extract	NULL
from	NULL
U-87MG	NULL
cells	NULL
stimulated	NULL
with	NULL
PMA	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
(	NULL
in	NULL
hours	NULL
)	NULL
(	NULL
lanes	NULL
3	NULL
to	NULL
7	NULL
)	NULL
.	NULL

The	NULL
intensity	NULL
of	NULL
the	NULL
bands	NULL
was	NULL
determined	NULL
by	NULL
densitometry	NULL
of	NULL
multiple	NULL
experiments	NULL
.	NULL

Representative	NULL
gels	NULL
are	NULL
shown	NULL
.	NULL

ates	NULL
an	NULL
RNA	NULL
of	NULL
356	NULL
nucleotides	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

Template	NULL
-117/+3	NULL
,	NULL
in	NULL
which	NULL
all	NULL
HIV-1	NULL
sequences	NULL
downstream	NULL
of	NULL
+3	NULL
,	NULL
including	NULL
TAR	NULL
,	NULL
are	NULL
removed	NULL
,	NULL
generates	NULL
a	NULL
279-nucleotide	NULL
runoff	NULL
transcript	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

These	NULL
transcripts	NULL
are	NULL
not	NULL
produced	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
0.5	NULL
pug	NULL
of	NULL
«	NULL
-amanitin	NULL
per	NULL
ml	NULL
,	NULL
demonstrating	NULL
their	NULL
dependence	NULL
on	NULL
RNA	NULL
polymerase	NULL
II	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
influence	NULL
of	NULL
astrocytic	NULL
nuclear	NULL
factors	NULL
on	NULL
HIV-1	NULL
transcription	NULL
in	NULL
vitro	NULL
,	NULL
HeLa	NULL
transcription	NULL
extracts	NULL
were	NULL
supplemented	NULL
with	NULL
astrocyte-derived	NULL
nuclear	NULL
extracts	NULL
.	NULL

In	NULL
this	NULL
and	NULL
subsequent	NULL
experiments	NULL
,	NULL
a	NULL
lesser	NULL
amount	NULL
of	NULL
template	NULL
DNA	NULL
was	NULL
utilized	NULL
to	NULL
decrease	NULL
basal	NULL
transcription	NULL
(	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

Supplementation	NULL
of	NULL
HeLa	NULL
transcription	NULL
extracts	NULL
with	NULL
nuclear	NULL
extract	NULL
from	NULL
unstimulated	NULL
U-87MG	NULL
astrocytes	NULL
had	NULL
negligible	NULL
influence	NULL
on	NULL
transcription	NULL
from	NULL
template	NULL
-117/+80	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

However	NULL
,	NULL
supplementation	NULL
of	NULL
HeLa	NULL
transcription	NULL
extract	NULL
with	NULL
nuclear	NULL
extract	NULL
from	NULL
PMA-stimulated	NULL
U-87MG	NULL
glial	NULL
astrocytes	NULL
resulted	NULL
in	NULL
a	NULL
transcriptional	NULL
activation	NULL
that	NULL
strongly	NULL
correlates	NULL
with	NULL
the	NULL
induction	NULL
of	NULL
«	NULL
B-binding	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
,	NULL
lanes	NULL
3	NULL
to	NULL
7	NULL
)	NULL
.	NULL

The	NULL
greatest	NULL
activation	NULL
in	NULL
transcription	NULL
is	NULL
seen	NULL
upon	NULL
addition	NULL
of	NULL
extract	NULL
stimulated	NULL
with	NULL
PMA	NULL
for	NULL
1	NULL
to	NULL
3	NULL
and	NULL
20	NULL
h	NULL
(	NULL
approxi-mately	NULL
eightfold	NULL
+	NULL
twofold	NULL
activation	NULL
in	NULL
multiple	NULL
experiments	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
densitometry	NULL
)	NULL
.	NULL

Transcription	NULL
from	NULL
template	NULL
3976	NULL
TAYLOR	NULL
ET	NULL
AL	NULL
.	NULL

A.	NULL
A17	NULL
-80	NULL
Sp1	NULL
+1	NULL
EcoR1	NULL
-117/+80	NULL
(	NULL
+TAR	NULL
)	NULL
-	NULL
s	NULL
Competitor	NULL
:	NULL
-	NULL
-	NULL
«	NULL
B	NULL
«	NULL
B	NULL
``	NULL
``	NULL
*	NULL
Glial	NULL
NE	NULL
:	NULL
-	NULL
oof	NULL
&	NULL
—-	NULL
)	NULL
«	NULL
sam	NULL
caviae	NULL
cames	NULL
g	NULL
_*	NULL
M	NULL
3	NULL
-	NULL
4	NULL
J.	NULL
Viror	NULL
.	NULL

417	NULL
ﬂwspl	NULL
+1	NULL
FUJI	NULL
”	NULL
-117/+3	NULL
(	NULL
-TAR	NULL
)	NULL
|	NULL
-m	NULL
@	NULL
@	NULL
ih	NULL
Competitor	NULL
:	NULL
-	NULL
-_	NULL
«	NULL
B	NULL
«	NULL
B	NULL
``	NULL
``	NULL
Glial	NULL
NE	NULL
:	NULL
--	NULL
+	NULL
+	NULL
+	NULL
-I	NULL
camas	NULL
cuimomee	NULL
canine	NULL
M	NULL
1	NULL
2	NULL
3	NULL
4	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Competition	NULL
with	NULL
wild-type	NULL
kB	NULL
oligonucleotides	NULL
,	NULL
but	NULL
not	NULL
mutant	NULL
kB	NULL
oligonucleotides	NULL
,	NULL
abolishes	NULL
transcriptional	NULL
activation	NULL
by	NULL
astrocytic	NULL
factors	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Template	NULL
-117/+80	NULL
.	NULL

The	NULL
arrow	NULL
indicates	NULL
the	NULL
356-nucleotide	NULL
transcript	NULL
.	NULL

The	NULL
transcriptional	NULL
activation	NULL
seen	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
20-h	NULL
PMA-stimulated	NULL
U-87MG	NULL
nuclear	NULL
extract	NULL
(	NULL
compare	NULL
lane	NULL
2	NULL
with	NULL
lane	NULL
1	NULL
)	NULL
is	NULL
blocked	NULL
by	NULL
preincubation	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
wild-type	NULL
«	NULL
B	NULL
sequence	NULL
(	NULL
GGGACTTTCC	NULL
)	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
but	NULL
not	NULL
by	NULL
1	NULL
jpg	NULL
of	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
mutated	NULL
«	NULL
B	NULL
sequence	NULL
(	NULL
CTCACTTTCC	NULL
)	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Template	NULL
-117/+3	NULL
.	NULL

The	NULL
arrow	NULL
points	NULL
to	NULL
the	NULL
279-nucleotide	NULL
transcript	NULL
(	NULL
the	NULL
lanes	NULL
are	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
panel	NULL
A	NULL
)	NULL
.	NULL

M	NULL
,	NULL
marker	NULL
;	NULL
R	NULL
,	NULL
nonspecific	NULL
reference	NULL
band	NULL
used	NULL
as	NULL
a	NULL
control	NULL
for	NULL
loading	NULL
;	NULL
NE	NULL
,	NULL
nuclear	NULL
extract	NULL
;	NULL
xB	NULL
``	NULL
,	NULL
mutated	NULL
B	NULL
sequence	NULL
;	NULL
+	NULL
,	NULL
present	NULL
;	NULL
-	NULL
,	NULL
absent	NULL
.	NULL

-117/+3	NULL
is	NULL
similarly	NULL
activated	NULL
by	NULL
PMA-stimulated	NULL
astrocytic	NULL
nuclear	NULL
extract	NULL
,	NULL
demonstrating	NULL
that	NULL
this	NULL
response	NULL
is	NULL
independent	NULL
of	NULL
the	NULL
TAR	NULL
element	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

However	NULL
,	NULL
deletion	NULL
of	NULL
the	NULL
«	NULL
B-binding	NULL
sites	NULL
,	NULL
utilizing	NULL
template	NULL
-80/+3	NULL
,	NULL
abolishes	NULL
the	NULL
transcriptional	NULL
enhancement	NULL
,	NULL
suggesting	NULL
that	NULL
factors	NULL
mediate	NULL
the	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
astrocytic	NULL
nuclear	NULL
factors	NULL
has	NULL
no	NULL
influence	NULL
on	NULL
transcription	NULL
directed	NULL
by	NULL
the	NULL
adenovirus	NULL
major	NULL
late	NULL
promoter	NULL
,	NULL
demonstrating	NULL
that	NULL
activation	NULL
is	NULL
not	NULL
a	NULL
general	NULL
phenomenon	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
astrocyte-derived	NULL
xB	NULL
activity	NULL
present	NULL
in	NULL
both	NULL
the	NULL
a	NULL
and	NULL
B	NULL
complexes	NULL
contributes	NULL
to	NULL
activation	NULL
of	NULL
HIV-1	NULL
transcription	NULL
.	NULL

Evidence	NULL
that	NULL
astrocyte-derived	NULL
«	NULL
B-binding	NULL
factors	NULL
are	NULL
responsible	NULL
for	NULL
transcriptional	NULL
activation	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
astrocytic	NULL
activity	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
transcriptional	NULL
activation	NULL
observed	NULL
upon	NULL
supplementation	NULL
of	NULL
the	NULL
HeLa	NULL
system	NULL
with	NULL
astrocytic	NULL
nuclear	NULL
factors	NULL
,	NULL
oligonucleotide	NULL
competitors	NULL
were	NULL
used	NULL
to	NULL
interrupt	NULL
interaction	NULL
of	NULL
<	NULL
B-binding	NULL
factors	NULL
with	NULL
the	NULL
promoter	NULL
.	NULL

The	NULL
induction	NULL
in	NULL
transcription	NULL
from	NULL
tem-	NULL
plate	NULL
-117/+80	NULL
seen	NULL
upon	NULL
supplementation	NULL
of	NULL
the	NULL
HeLa	NULL
extract	NULL
with	NULL
stimulated	NULL
astrocytic	NULL
nuclear	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
is	NULL
inhibited	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
excess	NULL
of	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
wild-type	NULL
«	NULL
kB-binding	NULL
sequence	NULL
(	NULL
GGGACTITCC	NULL
)	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
but	NULL
not	NULL
by	NULL
incubation	NULL
with	NULL
the	NULL
mutant	NULL
oligonucleotide	NULL
(	NULL
CTCACTTTCC	NULL
)	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Neither	NULL
wild-type	NULL
«	NULL
B	NULL
oligonucleotide	NULL
nor	NULL
mutant	NULL
kB	NULL
oligonucleotide	NULL
influences	NULL
the	NULL
basal	NULL
transcription	NULL
from	NULL
-117/+80	NULL
in	NULL
HeLa	NULL
extract	NULL
alone	NULL
(	NULL
unpublished	NULL
results	NULL
)	NULL
.	NULL

This	NULL
result	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
supposition	NULL
that	NULL
«	NULL
B-binding	NULL
proteins	NULL
are	NULL
responsible	NULL
for	NULL
the	NULL
observed	NULL
transcriptional	NULL
activation	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
the	NULL
same	NULL
«	NULL
B-dependent	NULL
induction	NULL
in	NULL
transcription	NULL
is	NULL
observed	NULL
with	NULL
template	NULL
-117/+3	NULL
,	NULL
which	NULL
does	NULL
not	NULL
contain	NULL
the	NULL
TAR	NULL
element	NULL
,	NULL
demonstrating	NULL
that	NULL
the	NULL
effect	NULL
is	NULL
not	NULL
TAR	NULL
dependent	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lanes	NULL
1	NULL
to	NULL
4	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
strongly	NULL
suggest	NULL
that	NULL
the	NULL
«	NULL
B-binding	NULL
activity	NULL
present	NULL
in	NULL
the	NULL
astrocytic	NULL
nuclear	NULL
extracts	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
observed	NULL
transcriptional	NULL
activation	NULL
.	NULL

TAR-independent	NULL
transactivation	NULL
by	NULL
Tat	NULL
is	NULL
dependent	NULL
on	NULL
VoL	NULL
.	NULL

68	NULL
,	NULL
1994	NULL
A	NULL
.	NULL

117	NULL
-§0	NULL
Spi	NULL
+1	NULL
EcoR1	NULL
=	NULL
c	NULL
-117/+80	NULL
(	NULL
+TAR	NULL
)	NULL
#	NULL
Ta	NULL
Glial	NULL
-	NULL
-+	NULL
Tat	NULL
-	NULL
+	NULL
-	NULL
-	NULL
Ae	NULL
1	NULL
-	NULL
'	NULL
3	NULL
%	NULL
~3-	NULL
4	NULL
CNS-DERIVED	NULL
«	NULL
B	NULL
REGULATION	NULL
OF	NULL
HIV-1	NULL
EXPRESSION	NULL
3977	NULL
B	NULL
.	NULL

417	NULL
-80	NULL
Spi	NULL
+1	NULL
EcoR1	NULL
§	NULL
117/43	NULL
(	NULL
-TAR	NULL
)	NULL
ig	NULL
``	NULL
*	NULL
U	NULL
1	NULL
°	NULL
2	NULL
3	NULL
4	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

TAR-independent	NULL
activation	NULL
of	NULL
HIV-1	NULL
transcription	NULL
by	NULL
Tat	NULL
in	NULL
vitro	NULL
requires	NULL
astrocytic	NULL
nuclear	NULL
factors	NULL
.	NULL

(	NULL
A	NULL
)	NULL
In	NULL
vitro	NULL
transcription	NULL
of	NULL
template	NULL
-117/+80	NULL
.	NULL

The	NULL
arrow	NULL
indicates	NULL
a	NULL
runoff	NULL
transcript	NULL
of	NULL
356	NULL
nucleotides	NULL
.	NULL

Lanes	NULL
:	NULL
1	NULL
,	NULL
basal	NULL
transcription	NULL
in	NULL
HeLa	NULL
transcription	NULL
extract	NULL
alone	NULL
;	NULL
2.	NULL
same	NULL
as	NULL
lane	NULL
1	NULL
with	NULL
the	NULL
addition	NULL
of	NULL
1	NULL
M	NULL
synthetic	NULL
Tat	NULL
protein	NULL
;	NULL
3	NULL
,	NULL
basal	NULL
transcription	NULL
in	NULL
HeLa	NULL
whole-cell	NULL
extract	NULL
supplemented	NULL
with	NULL
nuclear	NULL
extract	NULL
from	NULL
unstimulated	NULL
U-87MG	NULL
astrocytes	NULL
;	NULL
4	NULL
,	NULL
same	NULL
as	NULL
lane	NULL
3	NULL
with	NULL
the	NULL
addition	NULL
of	NULL
1	NULL
M	NULL
synthetic	NULL
Tat	NULL
protein	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Template	NULL
-117/+3	NULL
.	NULL

The	NULL
arrow	NULL
indicates	NULL
a	NULL
runoff	NULL
transcript	NULL
of	NULL
279	NULL
nucleotides	NULL
.	NULL

The	NULL
lanes	NULL
are	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
panel	NULL
A.	NULL
R	NULL
,	NULL
nonspecific	NULL
reference	NULL
band	NULL
used	NULL
as	NULL
a	NULL
control	NULL
for	NULL
loading	NULL
:	NULL
-	NULL
,	NULL
absent	NULL
:	NULL
+	NULL
,	NULL
present	NULL
.	NULL

The	NULL
intensity	NULL
of	NULL
the	NULL
bands	NULL
was	NULL
determined	NULL
by	NULL
densitometry	NULL
of	NULL
multiple	NULL
experiments	NULL
.	NULL

Representative	NULL
gels	NULL
are	NULL
shown	NULL
.	NULL

astrocyte	NULL
nuclear	NULL
factors	NULL
.	NULL

TAR-dependent	NULL
activation	NULL
of	NULL
HIV-1	NULL
transcription	NULL
by	NULL
Tat	NULL
can	NULL
be	NULL
observed	NULL
in	NULL
vitro	NULL
with	NULL
the	NULL
HeLa	NULL
whole-cell	NULL
system	NULL
,	NULL
as	NULL
has	NULL
been	NULL
previously	NULL
reported	NULL
(	NULL
29	NULL
,	NULL
36	NULL
)	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
an	NULL
optimal	NULL
concentration	NULL
(	NULL
1	NULL
wM	NULL
)	NULL
of	NULL
synthetic	NULL
Tat	NULL
results	NULL
in	NULL
approximately	NULL
a	NULL
sevenfold	NULL
+	NULL
twofold	NULL
increase	NULL
in	NULL
transcription	NULL
from	NULL
the	NULL
-117/+80	NULL
template	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
Tat	NULL
to	NULL
activate	NULL
HIV-1	NULL
transcription	NULL
in	NULL
the	NULL
HeLa	NULL
system	NULL
is	NULL
dependent	NULL
on	NULL
TAR	NULL
,	NULL
as	NULL
demonstrated	NULL
by	NULL
the	NULL
inability	NULL
of	NULL
Tat	NULL
to	NULL
activate	NULL
transcription	NULL
from	NULL
template	NULL
-117/	NULL
+3	NULL
,	NULL
which	NULL
has	NULL
the	NULL
TAR	NULL
element	NULL
removed	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

Our	NULL
previous	NULL
studies	NULL
carried	NULL
out	NULL
in	NULL
vivo	NULL
indicated	NULL
that	NULL
astrocytes	NULL
support	NULL
TAR-independent	NULL
activation	NULL
of	NULL
HIV-1	NULL
transcription	NULL
by	NULL
Tat	NULL
(	NULL
60	NULL
)	NULL
.	NULL

Supplementation	NULL
of	NULL
HeLa	NULL
transcription	NULL
extract	NULL
with	NULL
nuclear	NULL
factors	NULL
from	NULL
unstimulated	NULL
U-87MG	NULL
astrocytes	NULL
does	NULL
not	NULL
influence	NULL
transactivation	NULL
of	NULL
template	NULL
-117/+80	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
nuclear	NULL
factors	NULL
from	NULL
unstimulated	NULL
astrocytes	NULL
contributes	NULL
to	NULL
an	NULL
approximately	NULL
4.5-fold	NULL
*	NULL
2-fold	NULL
activation	NULL
of	NULL
transcription	NULL
by	NULL
Tat	NULL
from	NULL
template	NULL
-117/+3	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
,	NULL
demonstrating	NULL
TAR-independent	NULL
activation	NULL
in	NULL
vitro	NULL
.	NULL

Interestingly	NULL
,	NULL
when	NULL
this	NULL
experiment	NULL
was	NULL
performed	NULL
with	NULL
PMA-stimulated	NULL
astrocytic	NULL
nuclear	NULL
extracts	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
Tat	NULL
resulted	NULL
in	NULL
a	NULL
decrease	NULL
in	NULL
transcription	NULL
,	NULL
possibly	NULL
representing	NULL
a	NULL
squelching	NULL
phenome-non	NULL
.	NULL

Similar	NULL
decreases	NULL
in	NULL
transcription	NULL
were	NULL
observed	NULL
with	NULL
3-and	NULL
20-h	NULL
PMA-stimulated	NULL
glial	NULL
extract	NULL
(	NULL
unpublished	NULL
observation	NULL
)	NULL
.	NULL

Supplementation	NULL
of	NULL
the	NULL
HeLa	NULL
system	NULL
with	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
unstimulated	NULL
Jurkat	NULL
T	NULL
lymphocytes	NULL
does	NULL
not	NULL
permit	NULL
Tat	NULL
activation	NULL
of	NULL
the	NULL
TAR-deleted	NULL
-117/+3	NULL
template	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
,	NULL
further	NULL
suggesting	NULL
that	NULL
the	NULL
ability	NULL
to	NULL
support	NULL
TAR-independent	NULL
Tat	NULL
responsiveness	NULL
is	NULL
a	NULL
feature	NULL
unique	NULL
to	NULL
astrocytes	NULL
.	NULL

It	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
nuclear	NULL
extract	NULL
from	NULL
PMA-stimulated	NULL
Jurkat	NULL
T	NULL
cells	NULL
activates	NULL
HIV-1	NULL
transcription	NULL
in	NULL
vitro	NULL
(	NULL
33	NULL
)	NULL
.	NULL

It	NULL
has	NULL
also	NULL
been	NULL
reported	NULL
that	NULL
TAR-independent	NULL
replication	NULL
of	NULL
HIV-1	NULL
is	NULL
observed	NULL
in	NULL
PMA-stimulated	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
6	NULL
,	NULL
26	NULL
)	NULL
.	NULL

Perhaps	NULL
T-cell	NULL
activation	NULL
results	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
an	NULL
3978	NULL
TAYLOR	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
.	NULL

117	NULL
-808p1	NULL
+1	NULL
*	NULL
(	NULL
s	NULL
-117/+3	NULL
(	NULL
-TAR/+xB	NULL
)	NULL
T	NULL
cell	NULL
NE	NULL
:	NULL
Tat	NULL
:	NULL
1	NULL
#	NULL
3	NULL
J.	NULL
Viror	NULL
.	NULL

EcoR1	NULL
-80	NULL
Spi	NULL
+1	NULL
EcoRI	NULL
80/43	NULL
(	NULL
TAR/xB	NULL
)	NULL
Glial	NULL
NE	NULL
:	NULL
_-	NULL
_	NULL
-	NULL
+-	NULL
+	NULL
Tat	NULL
:	NULL
e	NULL
e	NULL
4	NULL
Jp	NULL
ma	NULL
#	NULL
2~s	NULL
.	NULL

3	NULL
aet	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Jurkat	NULL
T-cell	NULL
nuclear	NULL
factors	NULL
do	NULL
not	NULL
support	NULL
TAR-independent	NULL
Tat	NULL
transactivation	NULL
.	NULL

In	NULL
vitro	NULL
transcription	NULL
of	NULL
template	NULL
-117/+3	NULL
is	NULL
shown	NULL
.	NULL

The	NULL
arrow	NULL
indicates	NULL
a	NULL
runoff	NULL
transcript	NULL
of	NULL
279	NULL
nucleotides	NULL
.	NULL

Lanes	NULL
:	NULL
1	NULL
,	NULL
basal	NULL
transcription	NULL
in	NULL
HeLa	NULL
whole-cell	NULL
extract	NULL
alone	NULL
;	NULL
2	NULL
,	NULL
same	NULL
as	NULL
lane	NULL
1	NULL
with	NULL
the	NULL
addition	NULL
of	NULL
1	NULL
wM	NULL
synthetic	NULL
Tat	NULL
protein	NULL
;	NULL
3	NULL
,	NULL
basal	NULL
transcription	NULL
in	NULL
HeLa	NULL
whole-cell	NULL
extract	NULL
supplemented	NULL
with	NULL
nuclear	NULL
extract	NULL
from	NULL
unstimulated	NULL
Jurkat	NULL
T	NULL
cells	NULL
;	NULL
4	NULL
,	NULL
same	NULL
as	NULL
lane	NULL
3	NULL
with	NULL
the	NULL
addition	NULL
of	NULL
1	NULL
M	NULL
synthetic	NULL
Tat	NULL
protein	NULL
.	NULL

(	NULL
B	NULL
)	NULL
TAR-independent	NULL
transactivation	NULL
of	NULL
HIV-1	NULL
transcription	NULL
by	NULL
Tat	NULL
requires	NULL
the	NULL
«	NULL
B-binding	NULL
sites	NULL
.	NULL

In	NULL
vitro	NULL
transcription	NULL
of	NULL
template	NULL
-80/+3	NULL
is	NULL
shown	NULL
.	NULL

The	NULL
arrow	NULL
points	NULL
to	NULL
a	NULL
correctly	NULL
sized	NULL
runoff	NULL
transcript	NULL
of	NULL
279	NULL
nucleotides	NULL
.	NULL

Lanes	NULL
:	NULL
1	NULL
,	NULL
basal	NULL
transcription	NULL
in	NULL
HeLa	NULL
whole-cell	NULL
extract	NULL
alone	NULL
;	NULL
2	NULL
,	NULL
same	NULL
as	NULL
lane	NULL
1	NULL
with	NULL
the	NULL
addition	NULL
of	NULL
1	NULL
pM	NULL
synthetic	NULL
Tat	NULL
protein	NULL
;	NULL
3	NULL
,	NULL
basal	NULL
transcription	NULL
in	NULL
HeLa	NULL
whole-cell	NULL
extract	NULL
supplemented	NULL
with	NULL
nuclear	NULL
extract	NULL
from	NULL
unstimulated	NULL
astrocytes	NULL
;	NULL
4	NULL
,	NULL
same	NULL
as	NULL
lane	NULL
3	NULL
with	NULL
the	NULL
addition	NULL
of	NULL
1	NULL
uM	NULL
synthetic	NULL
Tat	NULL
protein	NULL
.	NULL

NE	NULL
,	NULL
nuclear	NULL
extract	NULL
;	NULL
-	NULL
,	NULL
absent	NULL
;	NULL
+	NULL
,	NULL
present	NULL
.	NULL

The	NULL
intensity	NULL
of	NULL
the	NULL
bands	NULL
was	NULL
determined	NULL
by	NULL
densitometry	NULL
of	NULL
multiple	NULL
experiments	NULL
.	NULL

Representative	NULL
gels	NULL
are	NULL
shown	NULL
.	NULL

VoL	NULL
.	NULL

68	NULL
,	NULL
1994	NULL
NF-	NULL
«	NULL
B-related	NULL
activity	NULL
that	NULL
is	NULL
common	NULL
to	NULL
,	NULL
and	NULL
enriched	NULL
in	NULL
,	NULL
astrocytes	NULL
.	NULL

Our	NULL
current	NULL
studies	NULL
are	NULL
examining	NULL
the	NULL
ability	NULL
of	NULL
PMA-stimulated	NULL
Jurkat	NULL
T	NULL
cells	NULL
to	NULL
support	NULL
TAR-independent	NULL
Tat	NULL
activation	NULL
in	NULL
vitro	NULL
and	NULL
the	NULL
relationship	NULL
of	NULL
this	NULL
mechanism	NULL
to	NULL
that	NULL
observed	NULL
in	NULL
astrocytes	NULL
(	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

TAR-independent	NULL
activation	NULL
of	NULL
HIV-1	NULL
in	NULL
vivo	NULL
was	NULL
found	NULL
to	NULL
be	NULL
mediated	NULL
by	NULL
the	NULL
kB	NULL
domain	NULL
of	NULL
the	NULL
viral	NULL
LTR	NULL
(	NULL
6	NULL
,	NULL
60	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
astrocytic	NULL
nuclear	NULL
factors	NULL
to	NULL
support	NULL
TAR-independent	NULL
Tat	NULL
responsiveness	NULL
in	NULL
vitro	NULL
requires	NULL
a	NULL
functional	NULL
xB-binding	NULL
site	NULL
.	NULL

Transcription	NULL
from	NULL
template	NULL
-80/+3	NULL
,	NULL
in	NULL
which	NULL
both	NULL
TAR	NULL
and	NULL
the	NULL
<	NULL
B-binding	NULL
sites	NULL
have	NULL
been	NULL
deleted	NULL
,	NULL
is	NULL
not	NULL
activated	NULL
by	NULL
Tat	NULL
,	NULL
implicating	NULL
the	NULL
astrocytic	NULL
«	NULL
B-binding	NULL
factors	NULL
as	NULL
mediators	NULL
of	NULL
Tat	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

Further	NULL
evidence	NULL
for	NULL
the	NULL
involvement	NULL
of	NULL
«	NULL
kB-binding	NULL
factors	NULL
in	NULL
mediating	NULL
Tat	NULL
transactivation	NULL
comes	NULL
from	NULL
competition	NULL
experiments	NULL
.	NULL

Excess	NULL
oligonucleotide	NULL
competitors	NULL
were	NULL
used	NULL
to	NULL
interrupt	NULL
interaction	NULL
of	NULL
«	NULL
B-binding	NULL
factors	NULL
with	NULL
the	NULL
promoter	NULL
.	NULL

Wild-type	NULL
kB	NULL
oligonucleotide	NULL
,	NULL
but	NULL
not	NULL
mutant	NULL
oligonucleotide	NULL
,	NULL
inhibited	NULL
Tat	NULL
activation	NULL
(	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

DISCUSSION	NULL
Differential	NULL
utilization	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
determined	NULL
by	NULL
different	NULL
subunit	NULL
combinations	NULL
or	NULL
interactions	NULL
with	NULL
modu-latory	NULL
activities	NULL
,	NULL
is	NULL
a	NULL
mechanism	NULL
by	NULL
which	NULL
a	NULL
cell	NULL
can	NULL
increase	NULL
the	NULL
functional	NULL
diversity	NULL
of	NULL
a	NULL
limited	NULL
number	NULL
of	NULL
gene	NULL
products	NULL
.	NULL

Such	NULL
diversity	NULL
is	NULL
observed	NULL
in	NULL
the	NULL
activity	NULL
and	NULL
specificity	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

In	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
specific	NULL
complex	NULL
of	NULL
p49-p65	NULL
works	NULL
in	NULL
concert	NULL
with	NULL
Tat	NULL
to	NULL
stimulate	NULL
HIV-1	NULL
transcription	NULL
,	NULL
while	NULL
a	NULL
complex	NULL
of	NULL
p50-p65	NULL
may	NULL
not	NULL
(	NULL
44	NULL
)	NULL
.	NULL

In	NULL
U-87MG	NULL
glial	NULL
astrocytes	NULL
,	NULL
a	NULL
newly	NULL
recognized	NULL
«	NULL
B-binding	NULL
activity	NULL
is	NULL
observed	NULL
which	NULL
is	NULL
retained	NULL
on	NULL
a	NULL
Tat	NULL
affinity	NULL
column	NULL
and	NULL
is	NULL
capable	NULL
of	NULL
activating	NULL
HIV-1	NULL
transcription	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
astrocyte-derived	NULL
«	NULL
B-binding	NULL
activity	NULL
is	NULL
responsible	NULL
for	NULL
mediating	NULL
TAR-independent	NULL
transactivation	NULL
by	NULL
Tat	NULL
.	NULL

Prototypical	NULL
NF-KB	NULL
consists	NULL
of	NULL
two	NULL
protein	NULL
subunits	NULL
,	NULL
50	NULL
and	NULL
65	NULL
kDa	NULL
,	NULL
termed	NULL
p50	NULL
and	NULL
p65	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
cloning	NULL
of	NULL
the	NULL
genes	NULL
encoding	NULL
p50	NULL
and	NULL
p65	NULL
allowed	NULL
recognition	NULL
that	NULL
they	NULL
were	NULL
both	NULL
related	NULL
by	NULL
homology	NULL
in	NULL
their	NULL
amino-terminal	NULL
region	NULL
to	NULL
the	NULL
product	NULL
of	NULL
the	NULL
rel	NULL
oncogene	NULL
.	NULL

In	NULL
vivo	NULL
,	NULL
prototypical	NULL
NF-kB	NULL
consists	NULL
of	NULL
a	NULL
heterodimeric	NULL
complex	NULL
of	NULL
p50	NULL
and	NULL
p65	NULL
which	NULL
is	NULL
sequestered	NULL
in	NULL
an	NULL
inactive	NULL
form	NULL
in	NULL
the	NULL
cytoplasm	NULL
by	NULL
association	NULL
of	NULL
the	NULL
p65	NULL
subunit	NULL
with	NULL
an	NULL
inhibitory	NULL
activity	NULL
,	NULL
IxB	NULL
(	NULL
3-5	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
is	NULL
rapidly	NULL
induced	NULL
by	NULL
dissociation	NULL
of	NULL
IxB	NULL
from	NULL
the	NULL
cytoplasmic	NULL
complex	NULL
,	NULL
allowing	NULL
nuclear	NULL
translocation	NULL
of	NULL
p50	NULL
and	NULL
p65	NULL
(	NULL
3-5	NULL
)	NULL
.	NULL

Upon	NULL
binding	NULL
DNA	NULL
,	NULL
both	NULL
p50	NULL
and	NULL
p65	NULL
contribute	NULL
to	NULL
transcriptional	NULL
activation	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
in	NULL
most	NULL
cell	NULL
types	NULL
,	NULL
occurs	NULL
independently	NULL
of	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
and	NULL
seems	NULL
to	NULL
involve	NULL
phosphorylation	NULL
of	NULL
the	NULL
inhibitor	NULL
IxB	NULL
(	NULL
24	NULL
,	NULL
27	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
a	NULL
gene	NULL
related	NULL
to	NULL
,	NULL
but	NULL
distinct	NULL
from	NULL
,	NULL
p50	NULL
was	NULL
cloned	NULL
(	NULL
51	NULL
)	NULL
.	NULL

The	NULL
product	NULL
of	NULL
this	NULL
gene	NULL
,	NULL
p49	NULL
,	NULL
is	NULL
capable	NULL
of	NULL
forming	NULL
a	NULL
complex	NULL
with	NULL
p65	NULL
which	NULL
activates	NULL
HIV-1	NULL
transcription	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
44	NULL
,	NULL
51	NULL
)	NULL
.	NULL

Evidence	NULL
suggests	NULL
that	NULL
the	NULL
heterodimeric	NULL
complex	NULL
p49-p65	NULL
,	NULL
but	NULL
not	NULL
pS50-p65	NULL
,	NULL
works	NULL
in	NULL
concert	NULL
with	NULL
Tat	NULL
to	NULL
stimulate	NULL
HIV-1	NULL
transcription	NULL
,	NULL
demonstrating	NULL
that	NULL
functional	NULL
differences	NULL
result	NULL
from	NULL
different	NULL
combinations	NULL
of	NULL
«	NULL
kB-related	NULL
proteins	NULL
(	NULL
44	NULL
)	NULL
.	NULL

The	NULL
xkB-binding	NULL
factors	NULL
present	NULL
in	NULL
astrocytes	NULL
show	NULL
characteristics	NULL
of	NULL
prototypical	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
such	NULL
as	NULL
specificity	NULL
of	NULL
binding	NULL
,	NULL
inducibility	NULL
by	NULL
PMA	NULL
,	NULL
and	NULL
the	NULL
bimodal	NULL
kinetics	NULL
of	NULL
this	NULL
induction	NULL
.	NULL

However	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
of	NULL
the	NULL
kB	NULL
complexes	NULL
derived	NULL
from	NULL
astrocytes	NULL
differs	NULL
from	NULL
that	NULL
of	NULL
those	NULL
seen	NULL
in	NULL
lymphocytes	NULL
,	NULL
demonstrating	NULL
heterogeneity	NULL
.	NULL

The	NULL
a	NULL
complex	NULL
derived	NULL
from	NULL
U-87MG	NULL
cells	NULL
comigrates	NULL
with	NULL
the	NULL
B1	NULL
complex	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
and	NULL
is	NULL
induced	NULL
with	NULL
similar	NULL
kinetics	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
(	NULL
38	NULL
)	NULL
.	NULL

CNS-DERIVED	NULL
«	NULL
kB	NULL
REGULATION	NULL
OF	NULL
HIV-1	NULL
EXPRESSION	NULL
3979	NULL
Further	NULL
,	NULL
two-dimensional	NULL
UV	NULL
cross-linking	NULL
experiments	NULL
strongly	NULL
suggest	NULL
that	NULL
astrocytic	NULL
a	NULL
and	NULL
lymphocytic	NULL
B1	NULL
complexes	NULL
contain	NULL
the	NULL
same	NULL
proteins	NULL
in	NULL
the	NULL
same	NULL
stoichiometry	NULL
(	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
observations	NULL
suggest	NULL
that	NULL
the	NULL
«	NULL
complex	NULL
is	NULL
the	NULL
U-87MG	NULL
equivalent	NULL
of	NULL
the	NULL
Jurkat	NULL
B1	NULL
complex	NULL
,	NULL
both	NULL
representing	NULL
prototypical	NULL
NF-kB	NULL
.	NULL

Most	NULL
interesting	NULL
,	NULL
however	NULL
,	NULL
is	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
more	NULL
slowly	NULL
migrating	NULL
kB-binding	NULL
complex	NULL
B	NULL
in	NULL
U-87MG	NULL
cells	NULL
which	NULL
has	NULL
no	NULL
readily	NULL
observable	NULL
counterpart	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

It	NULL
is	NULL
the	NULL
astrocyte-derived	NULL
B	NULL
complex	NULL
which	NULL
is	NULL
retained	NULL
on	NULL
the	NULL
Tat	NULL
affinity	NULL
column	NULL
,	NULL
a	NULL
feature	NULL
not	NULL
observed	NULL
for	NULL
either	NULL
the	NULL
astrocyte-derived	NULL
a	NULL
complex	NULL
or	NULL
the	NULL
Jurkat-derived	NULL
NF-KB	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

The	NULL
B	NULL
complex	NULL
may	NULL
be	NULL
composed	NULL
of	NULL
novel	NULL
,	NULL
CNS-specific	NULL
proteins	NULL
of	NULL
the	NULL
Rel	NULL
family	NULL
of	NULL
<	NULL
B-binding	NULL
factors	NULL
.	NULL

Preliminary	NULL
observations	NULL
suggest	NULL
,	NULL
however	NULL
,	NULL
that	NULL
the	NULL
B	NULL
complex	NULL
represents	NULL
a	NULL
supershifting	NULL
of	NULL
prototypical	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
a	NULL
CNS-enriched	NULL
activity	NULL
that	NULL
is	NULL
capable	NULL
of	NULL
interacting	NULL
with	NULL
Tat	NULL
.	NULL

The	NULL
<	NULL
B-binding	NULL
activities	NULL
of	NULL
U-87MG	NULL
cells	NULL
are	NULL
demonstrated	NULL
to	NULL
activate	NULL
transcription	NULL
in	NULL
a	NULL
promoter-specific	NULL
manner	NULL
that	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
presence	NULL
of	NULL
kB-binding	NULL
sites	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
and	NULL
4	NULL
)	NULL
,	NULL
which	NULL
classifies	NULL
these	NULL
binding	NULL
activities	NULL
as	NULL
transcription	NULL
factors	NULL
.	NULL

It	NULL
is	NULL
likely	NULL
that	NULL
the	NULL
ability	NULL
of	NULL
astrocyte-derived	NULL
«	NULL
B	NULL
factors	NULL
to	NULL
interact	NULL
with	NULL
Tat	NULL
is	NULL
related	NULL
to	NULL
TAR-independent	NULL
Tat	NULL
transactivation	NULL
which	NULL
is	NULL
mediated	NULL
through	NULL
the	NULL
kB	NULL
domain	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
(	NULL
6	NULL
,	NULL
26	NULL
,	NULL
60	NULL
)	NULL
.	NULL

TAR-independent	NULL
transactivation	NULL
of	NULL
HIV-1	NULL
transcription	NULL
by	NULL
Tat	NULL
is	NULL
observed	NULL
in	NULL
vitro	NULL
and	NULL
,	NULL
as	NULL
expected	NULL
,	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
presence	NULL
of	NULL
both	NULL
astrocytic	NULL
nuclear	NULL
factors	NULL
and	NULL
«	NULL
B-binding	NULL
sites	NULL
within	NULL
the	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
Tat	NULL
to	NULL
potently	NULL
activate	NULL
the	NULL
rate	NULL
of	NULL
HIV-1	NULL
transcription	NULL
has	NULL
been	NULL
attributed	NULL
to	NULL
increased	NULL
efficiency	NULL
of	NULL
transcriptional	NULL
elongation	NULL
,	NULL
though	NULL
increased	NULL
transcriptional	NULL
initiation	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Tat	NULL
has	NULL
also	NULL
been	NULL
observed	NULL
(	NULL
reviewed	NULL
in	NULL
reference	NULL
22	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
proposed	NULL
that	NULL
Tat	NULL
functions	NULL
in	NULL
the	NULL
vicinity	NULL
of	NULL
the	NULL
HIV-1	NULL
promoter	NULL
to	NULL
bias	NULL
initiation	NULL
towards	NULL
the	NULL
formation	NULL
of	NULL
more-processive	NULL
transcription	NULL
complexes	NULL
.	NULL

This	NULL
model	NULL
is	NULL
consistent	NULL
with	NULL
results	NULL
implicating	NULL
the	NULL
participation	NULL
of	NULL
the	NULL
kB	NULL
domain	NULL
and	NULL
the	NULL
Spl	NULL
domain	NULL
in	NULL
Tat	NULL
transactivation	NULL
(	NULL
7	NULL
,	NULL
30	NULL
,	NULL
55	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
kinetic	NULL
studies	NULL
which	NULL
suggest	NULL
that	NULL
a	NULL
transient	NULL
interaction	NULL
between	NULL
Tat	NULL
and	NULL
nascent	NULL
TAR	NULL
RNA	NULL
is	NULL
sufficient	NULL
for	NULL
wild-type	NULL
levels	NULL
of	NULL
transactivation	NULL
(	NULL
8	NULL
,	NULL
28	NULL
)	NULL
.	NULL

In	NULL
other	NULL
systems	NULL
,	NULL
distinct	NULL
classes	NULL
of	NULL
RNA	NULL
polymerase	NULL
II	NULL
transcription	NULL
complexes	NULL
,	NULL
with	NULL
differing	NULL
efficiencies	NULL
of	NULL
elongation	NULL
,	NULL
have	NULL
been	NULL
observed	NULL
and	NULL
studied	NULL
(	NULL
37	NULL
)	NULL
,	NULL
and	NULL
evidence	NULL
suggests	NULL
that	NULL
their	NULL
formation	NULL
may	NULL
be	NULL
determined	NULL
by	NULL
specific	NULL
conditions	NULL
of	NULL
transcriptional	NULL
initiation	NULL
(	NULL
56	NULL
)	NULL
.	NULL

While	NULL
Tat	NULL
is	NULL
the	NULL
first	NULL
identified	NULL
promoter-specific	NULL
elongation	NULL
factor	NULL
,	NULL
it	NULL
would	NULL
not	NULL
be	NULL
surprising	NULL
to	NULL
discover	NULL
that	NULL
this	NULL
mechanism	NULL
of	NULL
transcriptional	NULL
regulation	NULL
is	NULL
not	NULL
unique	NULL
to	NULL
HIV-1	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
its	NULL
role	NULL
in	NULL
regulating	NULL
HIV-1	NULL
transcription	NULL
,	NULL
Tat	NULL
appears	NULL
to	NULL
play	NULL
other	NULL
roles	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
AIDS	NULL
.	NULL

This	NULL
probably	NULL
reflects	NULL
the	NULL
recently	NULL
recognized	NULL
ability	NULL
of	NULL
Tat	NULL
to	NULL
influence	NULL
the	NULL
expression	NULL
of	NULL
select	NULL
cellular	NULL
genes	NULL
(	NULL
11	NULL
,	NULL
50	NULL
,	NULL
58	NULL
)	NULL
.	NULL

Functional	NULL
interaction	NULL
between	NULL
Tat	NULL
and	NULL
cellular	NULL
transcription	NULL
factors	NULL
,	NULL
such	NULL
as	NULL
those	NULL
interacting	NULL
with	NULL
kB	NULL
,	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
initiating	NULL
the	NULL
cascade	NULL
of	NULL
altered	NULL
cellular	NULL
gene	NULL
expression	NULL
that	NULL
contributes	NULL
directly	NULL
to	NULL
disease	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
model	NULL
,	NULL
Tat	NULL
has	NULL
been	NULL
directly	NULL
implicated	NULL
in	NULL
the	NULL
development	NULL
of	NULL
immunodeficiency	NULL
(	NULL
11	NULL
,	NULL
62	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
development	NULL
of	NULL
Kaposi	NULL
's	NULL
sarcoma	NULL
(	NULL
18	NULL
,	NULL
63	NULL
)	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
are	NULL
grateful	NULL
to	NULL
S.	NULL
Khan	NULL
for	NULL
providing	NULL
synthetic	NULL
Tat	NULL
protein	NULL
and	NULL
to	NULL
J.	NULL
Rappaport	NULL
for	NULL
his	NULL
support	NULL
and	NULL
helpful	NULL
suggestions	NULL
.	NULL

We	NULL
thank	NULL
the	NULL
members	NULL
of	NULL
the	NULL
Molecular	NULL
Neurovirology	NULL
Section	NULL
of	NULL
the	NULL
Jefferson	NULL
Institute	NULL
of	NULL
Molecular	NULL
Medicine	NULL
for	NULL
sharing	NULL
their	NULL
reagents	NULL
and	NULL
ideas	NULL
.	NULL

3980	NULL
TAYLOR	NULL
ET	NULL
AL	NULL
.	NULL

We	NULL
also	NULL
acknowledge	NULL
the	NULL
assistance	NULL
of	NULL
Jennifer	NULL
Gordon	NULL
and	NULL
Cynthia	NULL
Schriver	NULL
for	NULL
their	NULL
editorial	NULL
work	NULL
and	NULL
preparation	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
Public	NULL
Health	NULL
Service	NULL
grants	NULL
awarded	NULL
to	NULL
KK	NULL
.	NULL

and	NULL
S.A.	NULL
REFERENCES	NULL
1	NULL
.	NULL

Arya	NULL
,	NULL
S.	NULL
K.	NULL
,	NULL
C.	NULL
Guo	NULL
,	NULL
S.	NULL
F.	NULL
Josephs	NULL
,	NULL
and	NULL
F.	NULL
Wong-Staal	NULL
.	NULL

1985	NULL
.	NULL

Trans-activator	NULL
gene	NULL
of	NULL
human	NULL
T-lymphotropic	NULL
virus	NULL
type	NULL
III	NULL
(	NULL
HTLV-III	NULL
)	NULL
.	NULL

Science	NULL
229:69-73.	NULL
.	NULL

Ausubel	NULL
,	NULL
F.	NULL
M.	NULL
,	NULL
R.	NULL
Brent	NULL
,	NULL
R.	NULL
E.	NULL
Kingston	NULL
,	NULL
D.	NULL
D.	NULL
Moore	NULL
,	NULL
J.	NULL
G.	NULL
Seidman	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Smith	NULL
,	NULL
and	NULL
K.	NULL
Struhl	NULL
.	NULL

1990	NULL
.	NULL

Current	NULL
protocols	NULL
in	NULL
molecular	NULL
biology	NULL
.	NULL

John	NULL
Wiley	NULL
&	NULL
Sons	NULL
,	NULL
Inc.	NULL
,	NULL
New	NULL
York	NULL
.	NULL

3	NULL
.	NULL

Baeverle	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1988	NULL
.	NULL

Activation	NULL
of	NULL
DNA-binding	NULL
activity	NULL
in	NULL
an	NULL
apparently	NULL
cytoplasmic	NULL
precursor	NULL
of	NULL
the	NULL
NF-kB	NULL
transcription	NULL
factor	NULL
.	NULL

Cell	NULL
53:211-217	NULL
.	NULL

4	NULL
.	NULL

Baeuverle	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1988	NULL
.	NULL

I-kappa	NULL
B	NULL
:	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
the	NULL
NF-kappa	NULL
B	NULL
transcription	NULL
factor	NULL
.	NULL

Science	NULL
242:540-546	NULL
.	NULL

5	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
65-kD	NULL
subunit	NULL
of	NULL
active	NULL
NF-kappa	NULL
B	NULL
is	NULL
required	NULL
for	NULL
inhibition	NULL
of	NULL
NF-kappa	NULL
B	NULL
by	NULL
I-kappa	NULL
B	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

3:1689-1698	NULL
.	NULL

6	NULL
.	NULL

Bagasra	NULL
,	NULL
O.	NULL
,	NULL
K.	NULL
Khalili	NULL
,	NULL
T.	NULL
Seshamma	NULL
,	NULL
J.	NULL
P.	NULL
Taylor	NULL
,	NULL
and	NULL
R.	NULL
J.	NULL
Pomerantz	NULL
.	NULL

1992	NULL
.	NULL

TAR-independent	NULL
replication	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
in	NULL
glial	NULL
cells	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:7522-7528	NULL
.	NULL

7	NULL
.	NULL

Berkhout	NULL
,	NULL
B.	NULL
,	NULL
A.	NULL
Gatignol	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
Rabson	NULL
,	NULL
and	NULL
K.-T.	NULL
Jeang	NULL
.	NULL

1990	NULL
.	NULL

TAR-independent	NULL
activation	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
:	NULL
evidence	NULL
that	NULL
Tat	NULL
requires	NULL
specific	NULL
regions	NULL
of	NULL
the	NULL
promoter	NULL
.	NULL

Cell	NULL
62:757-767	NULL
.	NULL

8	NULL
.	NULL

Berkhout	NULL
,	NULL
B.	NULL
,	NULL
R.	NULL
H.	NULL
Silverman	NULL
,	NULL
and	NULL
K.-T.	NULL
Jeang	NULL
.	NULL

1989	NULL
.	NULL

Tat	NULL
trans-activates	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
through	NULL
a	NULL
nascent	NULL
RNA	NULL
target	NULL
.	NULL

Cell	NULL
59:273-282	NULL
.	NULL

9	NULL
.	NULL

Bohan	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
F.	NULL
Kashanchi	NULL
,	NULL
B.	NULL
Ensoli	NULL
,	NULL
L.	NULL
Buonaguro	NULL
,	NULL
K.	NULL
A.	NULL
Boris-Lawrie	NULL
,	NULL
and	NULL
J.	NULL
N.	NULL
Brady	NULL
.	NULL

1992	NULL
.	NULL

Analysis	NULL
of	NULL
Tat	NULL
transactivation	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
transcription	NULL
in	NULL
vitro	NULL
.	NULL

Gene	NULL
Expr	NULL
.	NULL

2:39	NULL
1-407	NULL
.	NULL

10	NULL
.	NULL

Bohnlein	NULL
,	NULL
E.	NULL
,	NULL
J.	NULL
W.	NULL
Lowenthal	NULL
,	NULL
M.	NULL
Sickevitz	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
B.	NULL
R.	NULL
Franza	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1988	NULL
.	NULL

The	NULL
same	NULL
inducible	NULL
nuclear	NULL
proteins	NULL
regulate	NULL
mitogen	NULL
activation	NULL
of	NULL
both	NULL
interleukin-2	NULL
recep-tor-alpha	NULL
gene	NULL
and	NULL
type	NULL
1	NULL
HIV	NULL
.	NULL

Cell	NULL
53:827-836	NULL
.	NULL

11	NULL
.	NULL

Buonaguro	NULL
,	NULL
L.	NULL
,	NULL
G.	NULL
Barillari	NULL
,	NULL
H.	NULL
K.	NULL
Chang	NULL
,	NULL
C.	NULL
A.	NULL
Bohan	NULL
,	NULL
V.	NULL
Kao	NULL
,	NULL
R.	NULL
Morgan	NULL
,	NULL
R.	NULL
C.	NULL
Gallo	NULL
,	NULL
and	NULL
B.	NULL
Ensoli	NULL
.	NULL

1992	NULL
.	NULL

Effects	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
Tat	NULL
protein	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
inflammatory	NULL
cytokines	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:7159-7167	NULL
.	NULL

12	NULL
.	NULL

Calnan	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
S.	NULL
Biancalana	NULL
,	NULL
D.	NULL
Hudson	NULL
,	NULL
and	NULL
A.	NULL
D.	NULL
Frankel	NULL
.	NULL

1991	NULL
.	NULL

Analysis	NULL
of	NULL
arginine-rich	NULL
peptides	NULL
from	NULL
HIV	NULL
Tat	NULL
protein	NULL
reveals	NULL
unusual	NULL
features	NULL
of	NULL
RNA-protein	NULL
recognition	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

5:201-210	NULL
.	NULL

13	NULL
.	NULL

Calnan	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
B.	NULL
Tidor	NULL
,	NULL
S.	NULL
Biancalana	NULL
,	NULL
D.	NULL
Hudson	NULL
,	NULL
and	NULL
A.	NULL
D.	NULL
Frankel	NULL
.	NULL

1991	NULL
.	NULL

Arginine-mediated	NULL
RNA	NULL
recognition	NULL
:	NULL
the	NULL
arginine	NULL
fork	NULL
.	NULL

Science	NULL
252:1167-1171	NULL
.	NULL

14	NULL
.	NULL

Cheng-Mayer	NULL
,	NULL
C.	NULL
,	NULL
J.	NULL
T.	NULL
Rutka	NULL
,	NULL
M.	NULL
L.	NULL
Rosenblum	NULL
,	NULL
T.	NULL
McHugh	NULL
,	NULL
D.	NULL
P.	NULL
Stites	NULL
,	NULL
and	NULL
J	NULL
.	NULL

Levy	NULL
.	NULL

1987	NULL
.	NULL

Human	NULL
immunodeficiency	NULL
virus	NULL
can	NULL
productively	NULL
infect	NULL
cultured	NULL
human	NULL
glial	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
$	NULL
4:3526-3530	NULL
.	NULL

15	NULL
.	NULL

Chiodi	NULL
,	NULL
F.	NULL
S.	NULL
,	NULL
S.	NULL
Fuerstenberg	NULL
,	NULL
M.	NULL
Gidlund	NULL
,	NULL
B.	NULL
Asjo	NULL
,	NULL
and	NULL
E.	NULL
M.	NULL
Fenyo	NULL
.	NULL

1987	NULL
.	NULL

Infection	NULL
of	NULL
brain-derived	NULL
cells	NULL
with	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

61:1244-1247	NULL
.	NULL

16	NULL
.	NULL

Dayton	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
J.	NULL
G.	NULL
Sodroski	NULL
,	NULL
C.	NULL
A.	NULL
Rosen	NULL
,	NULL
W.	NULL
C.	NULL
Goh	NULL
,	NULL
and	NULL
W.	NULL
A.	NULL
Haseltine	NULL
.	NULL

1986	NULL
.	NULL

The	NULL
trans-activator	NULL
gene	NULL
of	NULL
the	NULL
human	NULL
T	NULL
cell	NULL
lymphotropic	NULL
virus	NULL
type	NULL
II	NULL
is	NULL
required	NULL
for	NULL
replication	NULL
.	NULL

Cell	NULL
44:941-947	NULL
.	NULL

17	NULL
.	NULL

Dewhurst	NULL
,	NULL
S.	NULL
,	NULL
J.	NULL
Bresser	NULL
,	NULL
M.	NULL
Stevenson	NULL
,	NULL
K.	NULL
Sakai	NULL
,	NULL
M.	NULL
J.	NULL
Evinger-Hodges	NULL
,	NULL
and	NULL
D.	NULL
J.	NULL
Volsky	NULL
.	NULL

1987	NULL
.	NULL

Susceptibility	NULL
of	NULL
human	NULL
glial	NULL
cells	NULL
to	NULL
infection	NULL
with	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
HIV	NULL
)	NULL
.	NULL

FEBS	NULL
Lett	NULL
.	NULL

213:138-143	NULL
.	NULL

18	NULL
.	NULL

Ensoli	NULL
,	NULL
B.	NULL
,	NULL
G.	NULL
Barillari	NULL
,	NULL
S.	NULL
Z.	NULL
Salahuddin	NULL
,	NULL
R.	NULL
C.	NULL
Gallo	NULL
,	NULL
and	NULL
F.	NULL
Wong-Staal	NULL
.	NULL

1990	NULL
.	NULL

Tat	NULL
protein	NULL
of	NULL
HIV-1	NULL
stimulates	NULL
growth	NULL
of	NULL
cells	NULL
derived	NULL
from	NULL
Kaposi	NULL
's	NULL
sarcoma	NULL
lesions	NULL
of	NULL
AIDS	NULL
patients	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
345:84-86	NULL
.	NULL

19	NULL
.	NULL

Feinberg	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
D.	NULL
Baltimore	NULL
,	NULL
and	NULL
A.	NULL
D.	NULL
Frankel	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
role	NULL
of	NULL
Tat	NULL
in	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
life	NULL
cycle	NULL
indicates	NULL
a	NULL
primary	NULL
effect	NULL
on	NULL
transcription	NULL
elongation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:4045-4049	NULL
.	NULL

20	NULL
.	NULL

Fisher	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
M.	NULL
B.	NULL
Feinberg	NULL
,	NULL
S.	NULL
F.	NULL
Josephs	NULL
,	NULL
M.	NULL
E.	NULL
Harper	NULL
,	NULL
L.	NULL
M.	NULL
bo	NULL
21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

J.	NULL
ViroL	NULL
.	NULL

Marselle	NULL
,	NULL
G.	NULL
Reyes	NULL
,	NULL
M.	NULL
A.	NULL
Gonda	NULL
,	NULL
A.	NULL
Aldovini	NULL
,	NULL
C.	NULL
Debouck	NULL
,	NULL
R.	NULL
C.	NULL
Gallo	NULL
,	NULL
and	NULL
F.	NULL
Wong-Staal	NULL
.	NULL

1986	NULL
.	NULL

The	NULL
trans-activator	NULL
gene	NULL
of	NULL
HTLV-II	NULL
is	NULL
essential	NULL
for	NULL
virus	NULL
replication	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
320:367-371	NULL
.	NULL

Formosa	NULL
,	NULL
T.	NULL
,	NULL
J.	NULL
Barry	NULL
,	NULL
B.	NULL
M.	NULL
Alberts	NULL
,	NULL
and	NULL
J.	NULL
Greenblatt	NULL
.	NULL

1991	NULL
.	NULL

Using	NULL
protein	NULL
affinity	NULL
chromatography	NULL
to	NULL
probe	NULL
structure	NULL
of	NULL
protein	NULL
machines	NULL
.	NULL

Methods	NULL
Enzymol	NULL
.	NULL

208:24-45	NULL
.	NULL

Frankel	NULL
,	NULL
A.	NULL
D.	NULL
1992	NULL
.	NULL

Activation	NULL
of	NULL
HIV	NULL
transcription	NULL
by	NULL
Tat	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Gen.	NULL
Dev	NULL
.	NULL

2:293-298	NULL
.	NULL

Fujita	NULL
,	NULL
T.	NULL
,	NULL
G.	NULL
P.	NULL
Nolan	NULL
,	NULL
S.	NULL
Ghosh	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1992	NULL
.	NULL

Independent	NULL
modes	NULL
of	NULL
transcriptional	NULL
activation	NULL
by	NULL
the	NULL
p50	NULL
and	NULL
p65	NULL
subunits	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:775-787	NULL
.	NULL

Ghosh	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1990	NULL
.	NULL

Activation	NULL
in	NULL
vitro	NULL
of	NULL
NF-kB	NULL
by	NULL
phosphorylation	NULL
of	NULL
its	NULL
inhibitor	NULL
Ikb	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
344:678-682	NULL
.	NULL

Gyorkey	NULL
,	NULL
F.	NULL
,	NULL
J.	NULL
L.	NULL
Melnick	NULL
,	NULL
and	NULL
P.	NULL
Gyorkey	NULL
.	NULL

1987	NULL
.	NULL

Human	NULL
immunodeficiency	NULL
virus	NULL
in	NULL
brain	NULL
biopsies	NULL
of	NULL
patients	NULL
with	NULL
AIDS	NULL
and	NULL
progressive	NULL
encephalopathy	NULL
.	NULL

J.	NULL
Infect	NULL
.	NULL

Dis	NULL
.	NULL

155:870-876	NULL
.	NULL

Harrich	NULL
,	NULL
D.	NULL
,	NULL
J.	NULL
Garcia	NULL
,	NULL
R.	NULL
Mitsuyasu	NULL
,	NULL
and	NULL
R.	NULL
Gaynor	NULL
.	NULL

1990	NULL
.	NULL

TAR	NULL
independent	NULL
activation	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
in	NULL
phorbol	NULL
ester	NULL
stimulated	NULL
T	NULL
lymphocytes	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

94417-4423	NULL
.	NULL

Hohmann	NULL
,	NULL
H.-P.	NULL
,	NULL
R.	NULL
Remy	NULL
,	NULL
C.	NULL
Scheidereit	NULL
,	NULL
and	NULL
A.	NULL
P.	NULL
G.	NULL
M.	NULL
van	NULL
Loon	NULL
.	NULL

1991	NULL
.	NULL

Maintenance	NULL
of	NULL
NF-kB	NULL
activity	NULL
is	NULL
dependent	NULL
on	NULL
protein	NULL
synthesis	NULL
and	NULL
the	NULL
continuous	NULL
presence	NULL
of	NULL
external	NULL
stimuli	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:259-266	NULL
.	NULL

Jeang	NULL
,	NULL
K.-T.	NULL
,	NULL
and	NULL
B.	NULL
Berkhout	NULL
.	NULL

1992	NULL
.	NULL

Kinetics	NULL
of	NULL
HIV-1	NULL
long	NULL
terminal	NULL
repeat	NULL
trans-activation	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267:17891-17899	NULL
.	NULL

Jeyapaul	NULL
,	NULL
J.	NULL
,	NULL
M.	NULL
R.	NULL
Reddy	NULL
,	NULL
and	NULL
S.	NULL
A.	NULL
Khan	NULL
.	NULL

1990	NULL
.	NULL

Activity	NULL
of	NULL
synthetic	NULL
Tat	NULL
peptides	NULL
in	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
long	NULL
terminal	NULL
repeat-promoted	NULL
transcription	NULL
in	NULL
a	NULL
cell-free	NULL
system	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:7030-7034.	NULL
.	NULL

Kamine	NULL
,	NULL
J.	NULL
,	NULL
T.	NULL
Subramanian	NULL
,	NULL
and	NULL
G.	NULL
Chinnadurai	NULL
.	NULL

1991	NULL
.	NULL

Sp1	NULL
dependent	NULL
activation	NULL
of	NULL
a	NULL
synthetic	NULL
promoter	NULL
by	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
Tat	NULL
protein	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:8510-8514.	NULL
.	NULL

Korner	NULL
,	NULL
M.	NULL
,	NULL
A.	NULL
Rattner	NULL
,	NULL
F.	NULL
Mauxion	NULL
,	NULL
R.	NULL
Sen	NULL
,	NULL
and	NULL
Y.	NULL
Citri	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
brain-specific	NULL
transcription	NULL
activator	NULL
.	NULL

Neuron	NULL
3:563-572	NULL
.	NULL

Lechtenberg	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
J.	NULL
H.	NULL
Sher	NULL
.	NULL

1988	NULL
.	NULL

AIDS	NULL
in	NULL
the	NULL
nervous	NULL
system	NULL
.	NULL

Churchill	NULL
Livingstone	NULL
,	NULL
New	NULL
York	NULL
.	NULL

Li	NULL
,	NULL
Y.	NULL
C.	NULL
,	NULL
J.	NULL
Ross	NULL
,	NULL
J.	NULL
H.	NULL
Scheppler	NULL
,	NULL
and	NULL
B.	NULL
R.	NULL
Franza	NULL
,	NULL
Jr.	NULL
1991	NULL
.	NULL

An	NULL
in	NULL
vitro	NULL
analysis	NULL
of	NULL
early	NULL
response	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
long	NULL
terminal	NULL
repeat	NULL
to	NULL
different	NULL
transcriptional	NULL
activators	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:1883-1893	NULL
.	NULL

Liu	NULL
,	NULL
J.	NULL
,	NULL
N.	NULL
D.	NULL
Perkins	NULL
,	NULL
R.	NULL
M.	NULL
Schmid	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1992	NULL
.	NULL

Specific	NULL
NF-kB	NULL
subunits	NULL
act	NULL
in	NULL
concert	NULL
with	NULL
Tat	NULL
to	NULL
stimulate	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
transcription	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:3883-3887	NULL
.	NULL

Manley	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
A	NULL
.	NULL

Fire	NULL
,	NULL
A.	NULL
Cano	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

Sharp	NULL
,	NULL
and	NULL
M.	NULL
L.	NULL
Gefter	NULL
.	NULL

1980	NULL
.	NULL

DNA-dependent	NULL
transcription	NULL
of	NULL
adenovirus	NULL
genes	NULL
in	NULL
a	NULL
soluble	NULL
whole-cell	NULL
extract	NULL
.	NULL

Biochemistry	NULL
77:3855-3859	NULL
.	NULL

Marciniak	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
B.	NULL
J.	NULL
Calnan	NULL
,	NULL
A.	NULL
D.	NULL
Frankel	NULL
,	NULL
and	NULL
P.	NULL
A	NULL
.	NULL

Sharp	NULL
.	NULL

1990	NULL
.	NULL

HIV-1	NULL
Tat	NULL
protein	NULL
frans-activates	NULL
transcription	NULL
in	NULL
vitro	NULL
.	NULL

Cell	NULL
63:791-802	NULL
.	NULL

Marshall	NULL
,	NULL
N.	NULL
F.	NULL
,	NULL
and	NULL
D.	NULL
H.	NULL
Price	NULL
.	NULL

1992	NULL
.	NULL

Control	NULL
of	NULL
formation	NULL
of	NULL
two	NULL
distinct	NULL
classes	NULL
of	NULL
RNA	NULL
polymerase	NULL
II	NULL
elongation	NULL
complexes	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:2078-2090	NULL
.	NULL

Molitor	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
W.	NULL
H.	NULL
Walker	NULL
,	NULL
S.	NULL
Doerre	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1990	NULL
.	NULL

NF-kB	NULL
:	NULL
a	NULL
family	NULL
of	NULL
inducible	NULL
and	NULL
differentially	NULL
expressed	NULL
enhancer-binding	NULL
proteins	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:10028-10032	NULL
.	NULL

Muller	NULL
,	NULL
W.	NULL
E.	NULL
,	NULL
T.	NULL
Okamoto	NULL
,	NULL
P.	NULL
Reuter	NULL
,	NULL
D.	NULL
Ugarkovic	NULL
,	NULL
and	NULL
H.	NULL
C.	NULL
Schroder	NULL
.	NULL

1990	NULL
.	NULL

Functional	NULL
characterization	NULL
of	NULL
Tat	NULL
protein	NULL
from	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
.	NULL

Evidence	NULL
that	NULL
Tat	NULL
links	NULL
viral	NULL
RNAs	NULL
to	NULL
nuclear	NULL
matrix	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265:3803-3808	NULL
.	NULL

Nabel	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1987	NULL
.	NULL

An	NULL
inducible	NULL
transcription	NULL
factor	NULL
activates	NULL
expression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
326:711-714	NULL
.	NULL

Nabel	NULL
,	NULL
G.	NULL
J.	NULL
,	NULL
S.	NULL
A	NULL
.	NULL

Rice	NULL
,	NULL
D.	NULL
M.	NULL
Knipe	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1988	NULL
.	NULL

Alternative	NULL
mechanisms	NULL
for	NULL
activation	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
enhancer	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Science	NULL
239:1299-1301	NULL
.	NULL

Navia	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
E.	NULL
S.	NULL
Cho	NULL
,	NULL
C.	NULL
K.	NULL
Petito	NULL
,	NULL
and	NULL
R.	NULL
W.	NULL
Price	NULL
.	NULL

1986	NULL
.	NULL

The	NULL
AIDS	NULL
dementia	NULL
complex	NULL
:	NULL
II	NULL
.	NULL

Neuropathology	NULL
.	NULL

Ann	NULL
.	NULL

Neurol	NULL
.	NULL

19	NULL
:	NULL
525-535	NULL
.	NULL

VoL	NULL
.	NULL

68	NULL
,	NULL
1994	NULL
43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

Osborn	NULL
,	NULL
L.	NULL
,	NULL
S.	NULL
Kunkel	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1989	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
and	NULL
interleukin	NULL
1	NULL
stimulate	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
enhancer	NULL
by	NULL
activation	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
kB	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:2336-2340	NULL
.	NULL

Perkins	NULL
,	NULL
N.	NULL
D.	NULL
,	NULL
R.	NULL
M.	NULL
Schmid	NULL
,	NULL
C.	NULL
S.	NULL
Duckett	NULL
,	NULL
K.	NULL
Leung	NULL
,	NULL
N.	NULL
R.	NULL
Rice	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1992	NULL
.	NULL

Combinatorial	NULL
association	NULL
of	NULL
NF-kB	NULL
family	NULL
members	NULL
determine	NULL
the	NULL
specificity	NULL
of	NULL
DNA	NULL
binding	NULL
and	NULL
transcriptional	NULL
activation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:1529-1533	NULL
.	NULL

Pomerantz	NULL
,	NULL
R.	NULL
,	NULL
M.	NULL
B.	NULL
Feinberg	NULL
,	NULL
D.	NULL
Trono	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1990	NULL
.	NULL

Lipopolysaccharide	NULL
is	NULL
a	NULL
potent	NULL
monocyte/macrophage-specific	NULL
stimulator	NULL
of	NULL
HIV-1	NULL
replication	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

172:253-263	NULL
.	NULL

Ponten	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
E.	NULL
H.	NULL
Macintyre	NULL
.	NULL

1968	NULL
.	NULL

Long	NULL
term	NULL
culture	NULL
of	NULL
normal	NULL
and	NULL
neoplastic	NULL
human	NULL
glia	NULL
.	NULL

Acta	NULL
Pathol	NULL
.	NULL

Microbiol	NULL
.	NULL

Scand	NULL
.	NULL

74:465-486	NULL
.	NULL

Price	NULL
,	NULL
R.	NULL
W.	NULL
,	NULL
B.	NULL
J	NULL
.	NULL

Brew	NULL
,	NULL
and	NULL
M.	NULL
Rosenblum	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
AIDS	NULL
dementia	NULL
complex	NULL
,	NULL
p.	NULL
269-289	NULL
.	NULL

In	NULL
B.	NULL
H.	NULL
Waksman	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Immu-nologic	NULL
mechanisms	NULL
in	NULL
neurologic	NULL
and	NULL
psychiatric	NULL
disease	NULL
.	NULL

Raven	NULL
Press	NULL
,	NULL
New	NULL
York	NULL
.	NULL

Rosenblum	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
R.	NULL
M.	NULL
Levy	NULL
,	NULL
and	NULL
D.	NULL
E.	NULL
Bredesen	NULL
.	NULL

1988	NULL
.	NULL

AIDS	NULL
and	NULL
the	NULL
nervous	NULL
system	NULL
.	NULL

Raven	NULL
Press	NULL
,	NULL
New	NULL
York	NULL
.	NULL

Roy	NULL
,	NULL
S.	NULL
,	NULL
N.	NULL
T.	NULL
Parkin	NULL
,	NULL
C.	NULL
Rosen	NULL
,	NULL
J.	NULL
Itovitch	NULL
,	NULL
and	NULL
N.	NULL
Sonenberg	NULL
.	NULL

1990	NULL
.	NULL

Structural	NULL
requirements	NULL
for	NULL
frans	NULL
activation	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
long	NULL
terminal	NULL
repeat-directed	NULL
gene	NULL
expression	NULL
by	NULL
tart	NULL
:	NULL
importance	NULL
of	NULL
base	NULL
pairing	NULL
,	NULL
loop	NULL
sequence	NULL
,	NULL
and	NULL
bulges	NULL
in	NULL
the	NULL
fat-responsive	NULL
sequence	NULL
region	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:1402-1406	NULL
.	NULL

Sastry	NULL
,	NULL
K.	NULL
J.	NULL
,	NULL
R.	NULL
H.	NULL
R.	NULL
Reddy	NULL
,	NULL
R.	NULL
Pandita	NULL
,	NULL
K.	NULL
Totpal	NULL
,	NULL
and	NULL
B	NULL
.	NULL

B.	NULL
Aggarwal	NULL
.	NULL

1990	NULL
.	NULL

HIV-1	NULL
tat	NULL
gene	NULL
induces	NULL
tumor	NULL
necrosis	NULL
factor-B	NULL
(	NULL
lymphotoxin	NULL
)	NULL
in	NULL
a	NULL
human	NULL
B-lymphoblastoid	NULL
cell	NULL
line	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265:20091-20093	NULL
.	NULL

Schmid	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
N.	NULL
D.	NULL
Perkins	NULL
,	NULL
C.	NULL
S.	NULL
Duckett	NULL
,	NULL
P.	NULL
C.	NULL
Andrews	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1991	NULL
.	NULL

Cloning	NULL
an	NULL
NF-kB	NULL
subunit	NULL
which	NULL
stimulates	NULL
HIV	NULL
transcription	NULL
in	NULL
synergy	NULL
with	NULL
p65	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
352:733-736	NULL
.	NULL

Selby	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
B.	NULL
M.	NULL
Peterlin	NULL
.	NULL

1990	NULL
.	NULL

Trans-activation	NULL
by	NULL
HIV-1	NULL
Tat	NULL
via	NULL
a	NULL
heterologous	NULL
RNA	NULL
binding	NULL
protein	NULL
.	NULL

Cell	NULL
62:769-776	NULL
.	NULL

Sharp	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Marciniak	NULL
.	NULL

1989	NULL
.	NULL

HIV	NULL
TAR	NULL
:	NULL
an	NULL
RNA	NULL
enhancer	NULL
?	NULL

Cell	NULL
59:229-230	NULL
.	NULL

Sodroski	NULL
,	NULL
J.	NULL
,	NULL
R.	NULL
Patarca	NULL
,	NULL
C.	NULL
Rosen	NULL
,	NULL
F.	NULL
Wong-Staal	NULL
,	NULL
and	NULL
W.	NULL
CNS-DERIVED	NULL
«	NULL
B	NULL
REGULATION	NULL
OF	NULL
HIV-1	NULL
EXPRESSION	NULL
55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

64	NULL
.	NULL

3981	NULL
Haseltine	NULL
.	NULL

1985	NULL
.	NULL

Location	NULL
of	NULL
the	NULL
trans-activating	NULL
region	NULL
on	NULL
the	NULL
genome	NULL
of	NULL
human	NULL
T-cell	NULL
lymphotropic	NULL
virus	NULL
type	NULL
III	NULL
.	NULL

Science	NULL
229:74-77	NULL
.	NULL

Southgate	NULL
,	NULL
C.	NULL
,	NULL
M.	NULL
L.	NULL
Zapp	NULL
,	NULL
and	NULL
M.	NULL
R.	NULL
Green	NULL
.	NULL

1990	NULL
.	NULL

Activation	NULL
of	NULL
transcription	NULL
by	NULL
HIV-1	NULL
Tat	NULL
protein	NULL
tethered	NULL
to	NULL
nascent	NULL
RNA	NULL
through	NULL
another	NULL
protein	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
345:640-642	NULL
.	NULL

Spencer	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
and	NULL
M.	NULL
A.	NULL
Kilvert	NULL
.	NULL

1993	NULL
.	NULL

Transcription	NULL
elongation	NULL
in	NULL
the	NULL
human	NULL
c-myc	NULL
gene	NULL
is	NULL
governed	NULL
by	NULL
overall	NULL
transcription	NULL
initiation	NULL
levels	NULL
in	NULL
Xenopus	NULL
oocytes	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:1296-1305	NULL
.	NULL

Stoler	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
T.	NULL
A.	NULL
Eskin	NULL
,	NULL
S.	NULL
Benn	NULL
,	NULL
R.	NULL
C.	NULL
Angerer	NULL
,	NULL
and	NULL
L.	NULL
M.	NULL
Angerer	NULL
.	NULL

1986	NULL
.	NULL

Human	NULL
T-cell	NULL
lymphotropic	NULL
virus	NULL
type	NULL
III	NULL
infection	NULL
of	NULL
the	NULL
central	NULL
nervous	NULL
system	NULL
:	NULL
a	NULL
preliminary	NULL
in	NULL
situ	NULL
analysis	NULL
.	NULL

JAMA	NULL
256:2360-2364	NULL
.	NULL

Taylor	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
C.	NULL
Cupp	NULL
,	NULL
K.	NULL
Khalili	NULL
,	NULL
A.	NULL
Diaz	NULL
,	NULL
S.	NULL
Jimenez	NULL
,	NULL
and	NULL
S.	NULL
Amini	NULL
.	NULL

1992	NULL
.	NULL

Activation	NULL
of	NULL
expression	NULL
of	NULL
genes	NULL
coding	NULL
for	NULL
extra-cellular	NULL
matrix	NULL
proteins	NULL
in	NULL
Tat-producing	NULL
glioblastoma	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:9617-9621	NULL
.	NULL

Taylor	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
M.	NULL
Kundu	NULL
,	NULL
and	NULL
K.	NULL
Khalili	NULL
.	NULL

1993	NULL
.	NULL

TAR-independent	NULL
activation	NULL
of	NULL
HIV-1	NULL
requires	NULL
the	NULL
activation	NULL
domain	NULL
but	NULL
not	NULL
the	NULL
RNA-binding	NULL
domain	NULL
of	NULL
Tat	NULL
.	NULL

Virology	NULL
195:780-785	NULL
.	NULL

Taylor	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
R.	NULL
Pomerantz	NULL
,	NULL
O.	NULL
Bagasra	NULL
,	NULL
M.	NULL
Chowdhury	NULL
,	NULL
J.	NULL
Rappaport	NULL
,	NULL
K.	NULL
Khalili	NULL
,	NULL
and	NULL
S.	NULL
Amini	NULL
.	NULL

1992	NULL
.	NULL

TAR-independent	NULL
transactivation	NULL
by	NULL
Tat	NULL
in	NULL
cells	NULL
derived	NULL
from	NULL
the	NULL
CNS	NULL
:	NULL
a	NULL
novel	NULL
mechanism	NULL
of	NULL
HIV-1	NULL
gene	NULL
regulation	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

11:3395-3403	NULL
.	NULL

Tornatore	NULL
,	NULL
C.	NULL
,	NULL
A.	NULL
Nath	NULL
,	NULL
K.	NULL
Amemiya	NULL
,	NULL
and	NULL
E.	NULL
O	NULL
.	NULL

Major	NULL
.	NULL

1991	NULL
.	NULL

Persistent	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
infection	NULL
in	NULL
human	NULL
fetal	NULL
glial	NULL
cells	NULL
reactivated	NULL
by	NULL
T-cell	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
or	NULL
by	NULL
the	NULL
cytokines	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
and	NULL
interleukin-1	NULL
beta	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:6094-6100	NULL
.	NULL

Viscidi	NULL
,	NULL
R.	NULL
P.	NULL
,	NULL
K.	NULL
Mayur	NULL
,	NULL
H.	NULL
M.	NULL
Lederman	NULL
,	NULL
and	NULL
A.	NULL
D.	NULL
Frankel	NULL
.	NULL

1989	NULL
.	NULL

Inhibition	NULL
of	NULL
antigen-induced	NULL
lymphocyte	NULL
proliferation	NULL
by	NULL
Tat	NULL
protein	NULL
from	NULL
HIV-1	NULL
.	NULL

Science	NULL
246:1606-1608.	NULL
.	NULL

Vogel	NULL
,	NULL
J.	NULL
,	NULL
S.	NULL
H.	NULL
Hinrichs	NULL
,	NULL
R.	NULL
K.	NULL
Reynolds	NULL
,	NULL
P.	NULL
A.	NULL
Luciw	NULL
,	NULL
and	NULL
G.	NULL
Jay	NULL
.	NULL

1988	NULL
.	NULL

The	NULL
HIV	NULL
tat	NULL
gene	NULL
induces	NULL
dermal	NULL
lesions	NULL
resembling	NULL
Kaposi	NULL
's	NULL
sarcoma	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
335:606-611	NULL
.	NULL

Zimmerman	NULL
,	NULL
K.	NULL
,	NULL
M.	NULL
Dobrovnik	NULL
,	NULL
C.	NULL
Ballaun	NULL
,	NULL
D.	NULL
Bevec	NULL
,	NULL
J.	NULL
Hauber	NULL
,	NULL
and	NULL
E.	NULL
Bohnlein	NULL
.	NULL

1991.	NULL
frans-activation	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
by	NULL
HIV-1	NULL
Tat	NULL
and	NULL
HTLV-I	NULL
Tax	NULL
proteins	NULL
is	NULL
mediated	NULL
by	NULL
different	NULL
cis-acting	NULL
sequences	NULL
.	NULL

Virology	NULL
182:874-878	NULL
.	NULL

